Food safety and quality
| share
 

OECD Unique Identifier details

DAS-Ø15Ø7-1
Commodity: Corn / Maize
Traits: Glufosinate tolerance,Lepidoptera resistance
European Union
Name of product applicant: Pioneer and Dow AgroSciences
Summary of application:

The genetically modified maize 1507, as described in the application, expresses the Cry1F protein which confers resistance to the European corn borer (Ostrinia nubilalis) and certain other lepidopteran pests and the PAT protein which confers tolerance to glufosinate-ammonium based herbicides.

Upload:
Date of authorization: 21/12/2017
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): EU Register of authorised GMOs
Summary of the safety assessment (food safety):
Please see the EU relevant links below.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Method of detection: event specific real-time quantitative PCR based method for genetically modified maize DAS-Ø15Ø7-1. Reference material: ERM®-BF418 (for DAS-Ø15Ø7-1) is accessible via the Joint Research Centre (JRC) of the European Commission. Please see the EU relevant links below.
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: Opinion of the European Food Safety Authority
Method for Detection
Reference Material
Upload:
Authorization expiration date (a blank field means there is no expiration date) 22/12/2027
E-mail:
Organization/agency name (Full name):
European Union
Contact person name:
Alexandre Huchelmann
Website:
Physical full address:
European Commission B232 04/106 1047 Brussels
Phone number:
3222954092
Fax number:
Country introduction:

The process for authorising a new GMO is based on the EU regulation on GM food and feed (1829/2003). An application for authorising food or feed consisting of or made from a GMO must be submitted to the national authorities. The national authority then sends the application to the European Food Safety Agency (EFSA) for a risk assessment. EFSA then makes the application summary available to the public. No matter where in the EU the company applies, EFSA assesses the risks the GMO presents for the environment, human health and animal safety. If the application covers cultivation, EFSA delegates the environmental risk assessment to an EU country which sends EFSA its risk assessment report. After performing the risk assessment, EFSA submits its scientific opinion to the European Commission and to EU countries. The opinion is made available to the public, except for certain confidential aspects. Once EFSA publishes its risk assessment, the public has 30 days to comment on the Commission website for applications under Reg. 1829/2003, and on the Joint Research Centre website on the assessment report of the "lead" EU country for applications under Directive 2001/18. Within 3 months of receiving EFSA's opinion, the Commission grants or refuses the authorisation in a proposal. If it differs from EFSA’s opinion, it must explain why. National representatives approve the Commission’s proposal by qualified majority in: (1) The Standing Committee on the Food Chain and Animal Health if the application was submitted under Reg. 1829/2003; (2) The Regulatory Committee under Directive 2001/18/EC if the application was submitted under Dir. 2001/18. The proposal is adopted if the Committee agrees with it. If there is no opinion, the Commission may summon an Appeal Committee where EU countries can adopt or reject the proposal. If the Appeal Committee makes no decision, the Commission may adopt its proposal. Authorisations are valid for 10 years (renewable).

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
Australia
Name of product applicant: Dow AgroSciences Australia Pty Ltd
Summary of application:
The new genetic traits in the corn resulted from the introduction of two new genes encoding the bacterial proteins Cry 1F, conferring resistance to certain insect pests, and phosphinothricin acetyltransferase (PAT), an enzyme conferring tolerance to the synthetic herbicide, glufosinate-ammonium.

Bacillus thuringiensis, a common soil bacterium, produces a number of Cry proteins, known also as Bt proteins, with very selective insecticidal activity. One of the family of Cry proteins, known as Cry1F, has been shown in field research to be effective in controlling certain lepidopteran insect larvae such as those from the European Corn Borer (Ostrinia nubilalis), Southwestern corn borer (Diatraea grandiosella), black cutworm (Agrotis ipsilon) and armyworms (Spodoptera sp.). These insects are common pests of corn in the United States where it is intended for this variety to be grown commercially. The Cry1F protein is encoded by the cry1F gene derived from Bacillus thuringiensis subsp. aizawai.

The applicant claims that the presence of this genetic modification also results in a reduction in moulds and associated mycotoxins in the corn, in addition to the significant control of insect pests.

The PAT enzyme metabolises the herbicide glufosinate-ammonium (or L-phosphinothricin) into an inactive form. The enzyme is encoded by the pat gene which is derived from Streptomyces viridochromogenes, a common soil bacterium.

Corn is used predominantly as an ingredient in the manufacture of breakfast cereals, baking products, extruded confectionery and corn chips. Maize starch is used extensively by the food industry for the manufacture of many processed foods including dessert mixes and canned foods.

Despite the diverse uses of corn products in many foods, corn is a relatively minor crop in both Australia and New Zealand, with a declining area planted over the last decade. When required, products such as high-fructose corn syrup and maize starch are imported from major corn growing regions in the Northern Hemisphere, to meet manufacturing demand.

The cry1F gene is registered for full commercial use in the United States in field corn
originating from maize line 1507. Corn line 1507 has food, feed and
environmental approval in Japan (2002) and food, feed and cultivation approval in Canada (2002). It is also undergoing assessment in Korea and is awaiting assessment in the European Union. Foods derived from corn line 1507 may enter the Australian and New Zealand markets in the future via imported products.
Upload:
Date of authorization: 31/07/2003
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): OECD BioTrack Product Database
Summary of the safety assessment (food safety):
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: Application A446 - Insect/Glufosinate Resistant Corn line1507
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Food Standards Australia New Zealand
Contact person name:
Website:
Physical full address:
Level 4, 15 Lancaster Place, Majura Park ACT 2609, Australia
Phone number:
+61 2 6271 2222
Fax number:
+61 2 6271 2278
Country introduction:

Food Standards Australia New Zealand (FSANZ) is the regulatory agency responsible for the development of food standards in Australia and New Zealand. The main office (approximately 115 staff) is located in Canberra (in the Australian Capital Territory) and the smaller New Zealand office (approximately 10 staff) is located in Wellington on the North Island.

Useful links
Relevant documents
Stacked events:

FSANZ does not: Separately assess food from stacked event lines where food from the GM parents has already been approved; Mandate notification of stacked events by developers; Notify the public of stacked event ‘approvals’; List food derived from stacked event lines in the Code, unless the stacked event line has been separately assessed as a single line e.g. Application A518: MXB-13 cotton (DAS-21023-5 x DAS-24236-5)

No separate approval or safety assessment is necessary for foods derived from a stacked GM line that is the result of traditional breeding between a number of GM parent lines for which food has already been approved. Food from the parent lines must be listed in the Australia New Zealand Food Standards Code. The parent lines may contain any number of different genes. If food from any of the GM parent lines has not been approved, then a full pre-market safety assessment of food from the stacked line must be undertaken.

No separate approval is required for food derived from a line that is the product of a GM line, for which food has been approved, crossed traditionally with a non-GM line.

Where a single line containing a number of genes has been produced as a result of direct gene technology methods (rather than traditional crossing) then food derived from the line must undergo a full pre-market safety assessment before approval can be given

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Food Standards Australia New Zealand (FSANZ) (http://www.foodstandards.gov.au)

Brazil
Name of product applicant: Du Pont do Brasil & Dow AgroSicence
Summary of application:
commercial release of genetically modified corn, resistant to insect of the Lepidoptera order (Bt Cry1F 1507- Event TC1507 corn)
Upload:
Date of authorization: 11/12/2008
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): Center for Environmental Risk Assessment
Summary of the safety assessment (food safety):
TC1507 corn was obtained by genetic transformation through microparticle acceleration, or biobalistics. Immature corn embryo calluses of the hybrid Hi-II lineage corn were bombarded with insert PHI899A, containing genes cry1F and pat, region coming from plasmid PHP8999. Though plasmid PHP8999 has the nptII gene, it was not used in the process. Transformed calluses were cultivated in a selective medium containing glufosinate ammonium, and resistant plants were transferred to a plant nursery. The insecticide protein present in TC1507 corn is a Cry1F truncated protein derived from the PS81I (NRRL B-18484) of Bacillus thuringiensis var. aizawai. B. thuringiensis (Bt) is a gram-positive bacterium that has, at the moment of its sporulation, crystalline protein inclusions. The inclusions contain proteins denominated delta-endotoxins. These proteins are produced in the form of protoxines and transformed into toxic peptides at the insect bowels under the action of alkaline intestinal pH and proteases. The active toxin causes epithelial cell lysis and death of the larvae. Bacterium B. thuringiensis may be considered to be the biological agent with the greater potential to control forest and agricultural insect pests and disease vectors; given the specificity of delta-endotoxins to target insects and invertebrates, coupled with the bacterium innocuousness to vertebrates and the environment, including beneficial insects and natural enemies, make this agent a key component for strategies of plague controlled management. Since the sixties, B. thuringiensis (Bt) has been used in the United States as a pesticide to control butterflies. Different toxicity studies conducted in mammals with Bt clearly show the absence of toxicity and pathogenicity. Due to its use as a microbial pesticide, a long history of safe use has been associated to proteins produced by Bt. Nutritional and toxicological security tests have been reported evidencing innocuousness of the expressed protein. In addition to resistance to insects, corn TC1507 contains gene pat, derived from Streptomyces viridochromogenes strand Tu949, which is responsible for codifying enzyme phosphinothricin acetyltransferase (PAT), the sequence of which has 183 amino acids and is identical to the PAT protein present in hybrids of genetically modified commercially released corns. The recombinant enzyme PAT is able to chemically inactivate herbicides derived from phosphinothricin, like glufosinate ammonium, making cells and plants containing such enzyme resistant. PAT protein is degraded by gastric juices of animals and by artificial gastric juice similar to that of humans, losing its physicochemical characteristics after oral exposure. Therefore, one does not expect the protein to be entirely absorbed, being unlikely that it may bring adverse or toxic effects. Innocuousness of transformation by the pat gene is confirmed by works conducted by different research groups. A study with cows fed on a formulation containing isogenic and transgenic corn for such modification, revealed the similarity of yield and composition in milk produced by both groups of animals. The same work analyzed appearance of transgene fragments in 90 samples of milk along the experiment and failed to show any positive result of transposition of natural barriers and appearance of DNA fragments or fragments of its corresponding protein in the milk. Except for the characteristics of resistance to pest Lepidoptera insects and tolerance to glufosinate ammonium introduced by gens cry1F and pat, TC1507 corn did not undergo any other phenotypical change. Western Blot analysis confirmed that the cry1F and pat proteins expressed in the plant have the same molecular weight and immunoreactiveness of the protein derived from the microbial form expressed from P. fluorescens. Analyses of TC1507 corn regarding quality and quantity standards of metabolites normally found in corn demonstrated that event TC1507 is substantially equivalent to conventional varieties of corn. The assessments were conducted to define individual components that are part of human diet. Centesimal composition data analyses presented in the process encompass profile analysis of proteins, amino acids, fat acids, lipids, carbohydrates, minerals, vitamins, secondary metabolites, and composition of fodder and kernel, comparing event TC1507 with corn plants not genetically modified. The results obtained in Brazil and other countries failed to show variations that exceed the standards commonly found in non-genetically modified corn hybrids and lineages. Therefore, one may assume that TC1507 corn is substantially equivalent to non-genetically modified corn plants. Samples taken from leaves, pollen, kernel and the whole plant (vegetative tissues) of both, TC1507 and conventional corn lineages, were used to detect Cry1F and PAT proteins in transformed plants. Western Blot analyses showed that protein Cry1F is expressed in all tissues, in contrast to protein PAT that was detected only in leaves of the TC1507 lineage. In order to analyze the level of expression, samples of corn leaves, pollen, silk, stalk, whole plant, kernel, both normal and senescent of the TC1507 corn lineage, as well as samples from non-transformed corn plants were collected during the 1998-1999 crop and tested with the ELISA test. The results regarding total protein (TP) showed higher levels of the Cry1F protein expression in the whole plant (1063.8 pg Cry1F/ug TP), senescent whole plant (714.3 pg Cry1F/ug TP), stalk (550.0 pg Cry1F/ug TP) followed by pollen (135.5 pg Cry1F/ug TP), leaf (110.0 pg Cry1F/ug TP), grain (89.9pg Cry1F/ug TP) and silk (50.3 pg Cry1F/ug TP). Dispersion of corn seeds is easily controlled, since domestication of corn eliminated the ancient seed dispersion mechanisms and pollen movement is the only effective means for gene escaping of corn plants. Horizontal gene flow between TC1507 corn and other species, even those closely related, are practically unlikely to happen, since wile species related to corn do not occur naturally in Brazil. Coexistence between cultivars of conventional corn (either cultivated or Creole) and transgenic cultivars is possible from the agronomic viewpoint, and this is a reason to comply with the provisions of CTNBio Ruling Resolution no. 04. The use of genetically modified insect-tolerant plants has positive repercussions also in aspects related to obtaining, distributing and using chemical insecticides, for the significant reduction in the pollution brought by industrial waste and water used in insecticide sprinkling, in addition to avoiding contamination of man, food, rivers and water sources resulting from the use, transportation and storage of insecticides. For the foregoing, a conclusion is reached that cultivation and consumption of TC1507 corn is not a potential cause of significant degradation of the environment; or of risks to human and animal health. For these reasons, there is no restrictions to the use of this corn or its derivatives. The applicant shall conduct post-commercial release monitoring under the provisions of CTNBio Ruling Instruction no. 03. According to Article 1 of Law no. 11,460, of March 21, 2007, "research and cultivation of genetically modified organisms may not be conducted in Amerindian areas and conservation units”. ”. Regarding the scope of Article 14 of Law no. 11,105/05, CTNBio holds that the request complies with applicable legislation and regulation aimed at securing biosafety of the environment, agriculture, human and animal health. CTNBio Technical Opinion 1. GMO Identification GMO name: Bt Cry1F 1507 – Event TC1507 corn, Herculex Corn. Applicant: Dow Agrosciences Industrial Ltda. and Du Pont do Brasil S.A. – Division Pioneer Sementes. Species: Zea mays L. Inserted Feature: Tolerance to glufosinate ammonium herbicide and resistance to insects. Insertion method: Biobalistics, with the use of particle acceleration. Prospective use: Production of grains for human and animal consumption from the GMO and its derivatives. II. General Information Zea mays L., corn, is a monoic annual plant with height ranging from 1.0 to 4.0 meters(1). Its main stalk is composed of knots and inter-knots clearly defined. Inter-knots are wide at the basis and gradually diminish until inflorescence at the upper part of the plant. Leaves alternate along the stalk. Corn is the only grassy plant having both male and female flower structures in the same plant, though in different places(2). Corn has over eight thousand years of history in the Americas and is cultivated since the pre-Colombian period. Corn is one of the higher plants more well scientifically characterized, and today it is the cultivated species that reached the highest degree of domestication and can only survive in nature when cultivated by man(3). Currently, over 300 corn varieties have been identified and, within each variety, thousands of cultivars. Corn is one of the most important sources of food in the world and is the input for the production of a wide range of food products, fodder and industrial products. Brazil is the third largest world’s corn producer, and has harvested about 35 million tons in 2005, behind the United States of America (282 million tons) and China (139 million tons)(4). Corn is the second most cultivated grain in Brazil and is planted basically in two different crops (summer and safrinha, or small crop) and cultivated practically all over the domestic territory, with 75.68% concentrated in the Southern and Central Region and 24.32% in the Northern and Northeastern Region. In terms of Brazilian production, corn is second only to soybeans(5). It is a known fact that the insect population in the tropics is larger than in temperate zones, and that damages caused by them are more significant in the tropical zone. Among the most important corn plagues there is the fall armyworm (Spodoptera frugiperda). Cruz et. al.(6) estimated that losses in Brazil caused by infestations of S. frugiperda are about 400 million Dollars annually. Starting in 1999, there has been an increased occurrence of fall armyworm, and, consequently, larger losses have been recorded. Other species of the Lepidoptera order are also important corn plagues, such as corn earworm (Helicoverpa zea) and sugarcane borer (Diatraea saccharalis). It is estimated that these three species may damage up to 34% of corn kernel production. The main measure to control insects in corn culture has been the use of insecticides. In some areas of the Brazilian Center-Western Region, dozens of insecticide applications are needed in a single cultivation cycle. Another measure for pest control would be the use of resistant cultivars. Obtaining insect-resistant corn cultivars by classical genetic improvement has not attained the expected level of success. Considering fall armyworm, several attempts have achieved limited success(7). TC1507 corn possesses characteristics that grant resistance to insects and tolerance to the herbicide glufosinate ammonium. This means that the phenotype enables the corn to resist to the main pests of the Lepidoptera order affecting corn culture in Brazil. These characteristics result from genes that were introduced and codify a truncated form of the insecticide protein Cry1F, derived from strand PS81I (NRRL B-18484) of bacterium B. thuringiensis var. aizawai and one enzyme (phosphinothricin acetyltransferase, PAT), which grants tolerance to the herbicide glufosinate ammonium, also obtained from a soil bacterium, Streptomyces viridochromogenes. Corn varieties containing Cry proteins have been used in different countries of the world without any record that corn hybrids containing cry genes have caused damage to the environment, human and animal health. Commercial use of TC1507 corn has taken place in the United States of America since 2001, Argentina (2005), Colombia (2006), China (2004), Mexico (2003), South Africa (2002), Canada (2002), Australia (2003), Japan (2002), Korea (2002), Philippines (2003), Taiwan (2003), and European Union (2006) without identification of problems related to the agronomic characteristics of the event(8). Brazil is held as the third largest consumer of agriculture pest controlling substances in the world, where there are about 142 registered corn pesticides, from which 107 are intended for lizards. There are several reports of resistance caused by the constant and indiscriminate use of corn culture insecticides in Brazil. Besides, one of the most important causes of harm to the health of farmers in the country is the use of chemical pesticides, responsible for intoxicating one million individuals each year(9). TC1507 corn was tested in Brazilian fields, in several important regions for corn production since 1998. The TC1507 lineage has also been assessed in essays conducted in Argentina, Chile, South Africa, Colombia, United States and Europe since 1997. Plants derived from TC1507 corn lineage attained the expected yield, without evidence of unexpected changes in morphological and phenotypic characteristics. There was also no evidence that event TC1507 had acquired characteristics of a plant pest, both in experimental plots and in fields where the event is recorded for cultivation. III. Description of the GO and Proteins Expressed TC1507 corn was developed from a germplasm deemed appropriate for genetic modification. In order to transform corn embryos, a linear portion of plasmid PHP8999 DNA was extracted containing gene cry1F and the gene used as selective marker: pat. The linear DNA portion, namely the insert, was used in the transformation process. Corn plants of lineage TC1507 were obtained by microparticle bombarding, using a Biolistics accelerator PDS-1000He-Bio-Rad(10). No vector was used in the transformation of corn to generate event TC1507. From plasmid PHP8999 a linear fragment was extracted, named PHI8999A, containing the coding sequence of genes cry1F and pat, jointly with their associated elements of genic expression. The insecticide protein present in TC1507 corn is a truncated Cry1F protein derived from strain PS81I (NRRL B-18484) of Bacillus thuringiensis var. aizawai(11). B. thuringiensis (Bt) is a gram positive bacterium belonging to family Bacillaceae, producing, at the moment of sporulation, crystalline protein inclusions. The inclusions contain proteins named delta-endotoxins that currently form a family of 300 members, classified in 49 different groups(12). The proteins are produced as protoxines and are transformed into toxic peptides in the insect bowels under action of the intestinal alkaline pH and proteases. The active toxin causes lysis of epithelial cells and death of larvae(13, 14). B. thuringiensis may be considered the biologic agent of greater power in controlling forest, agricultural insect pests and disease vectors; due to the specificity of delta-endotoxins towards target insects and invertebrates and innocuousness to vertebrates and the environment, including beneficial insects and natural enemies(15), making this agent a key component in pest integrated management strategies(16). In addition to resistance to insects, TC1507 corn contains the pat gene, derived from Streptomyces viridochromogenes strain Tu494, responsible for codifying enzyme phosphinothricin acetyltransferase (PAT), the sequence of which has 183 amino acids and is identical to the PAT protein present in hybrids of genetically modified commercially released corns(17). The original sequence of the pat gene was modified to reduce G/C content and change the codon of the beginning of GTG translation into ATG, in a way to enable and optimize synthesizing the original protein. The final version of gene pat has 558 pb. Again, a sequence of 551 pb of CaMV 35S promoter (isolated Cabb-s) and the 178 pb IVS2 intron sequence of the corn gene adhS1 were used to promote and enhance the pat gene transcription. Sequence 3’-nos of 220 pb was used as a stop element of the transgene. The cassette therefore enables synthesizing the recombinant protein PAT, able to chemically inactivate herbicides derived from phosphinotricin, such as glufosinate ammonium, making resistant the cells and plants containing it. The PAT enzyme has its activity described and well known(18, 19, 20). Except for its resistance to Lepidoptera pest insects and tolerance to the glufosinate ammonium herbicide introduced by genes cry1F and pat, the TC1507 corn has no other phenotypic change. Western Blot analyses confirmed that proteins Cry1F and PAT expressed in the plant have the same molecular weight and immunoreactivity of the protein derived from the microbian form expressed from P. fluorescens (21). Gao et al.(22) also used similar methods to study the expression of gene cry1F in cotton. The results of a detailed molecular characterization of TC1507 corn using Southern Blot enabled a conclusion that this corn contain an almost complete copy of the DNA insert used in the transformation (i.e., 6186 pb of the 6235 pb fragment of insert PHI8999A, containing cry1F and pat genes jointly with the regulatory sequences needed in their expression). TC1507 corn is free from nptII gene and from any other detectable fragment of part of plasmid PHP8999 not intended in transforming the TC1507 corn. The flanking regions of the corn genomic DNA on borders 5’ and 3’ in the TC1507 insert were arranged in sequence and characterized in detail. IV. Aspects related to Human and Animal Health Security assessment of food derived from genetically modified raw-materials is based on risk analysis, a scientific methodology encompassing the phases of risk assessment, risk management and risk communication. In the risk assessment, one pursues the qualitative and quantitative characterization of potential adverse effects, based on the concept of substantial equivalence to identify any differences between the new food and its conventional correspondent. The Principle of Substantial Equivalence is a key concept in assessing the innocuousness of food generated from new technologies(23). When assessing the security of a genetically modified food raw-material, or its equivalence to conventional food, it is recommended that four elements are analyzed, namely: (1) Parental variety, i.e. the plant originating the new genetically modified raw-material; (2) Transformation process, including a characterization of the construct used and the resulting event; (3) Product of the inserted gene and potential toxicity and allergenicity and, finally; (4) Composition of the new variety resulting from genetic transformation. The data set of such analyses shall enable identifying and characterizing any potential adverse effect associated with consumption of the new raw-material, providing information to the risk management and risk communication phases. Since the sixties, B. thuringiensis (Bt) has been used in the United States of America as a pesticide to control Lepidoptera. Several toxicity studies in mammals conducted with Bt clearly show an absence of toxicity and pathogenicity(24). Due to its use as microbian pesticide, a long history of safe use has been associated to proteins produced by Bt(25). According to an assessment conducted by the United States Environment Protection Agency (EPA), Bt corns, including event TC1507 expressing protein Cry1F are harmless to human health(25). Grain nutrient analysis (proteins, fats, acid detergent fiber, neutral detergent fiber, carbohydrates, ashes and moist content) from the TC1507 corn hybrid, showed comparability with grain of commercial corn hybrids. Nutritional and toxicologic safety tests have been reported evidencing the innocuousness of the protein expressed. Highly relevant scientific articles attest the low risk and innocuousness of cultures containing the Bt toxin gene(26, 27). Assessment of substantial equivalence was made by Herman et al.(28). Concurrently with insect resistance, the Bt toxin contributes for reducing the development of corn ears molds, organisms responsible by the production of mycotoxins and consequent contamination of corn(29). A subchronic toxicity study was conducted with event TC1507 corn in male and female Sprague-Dawley rats(30). They received ad libitum food containing either TC1507 or conventional corn (control) grains, in a maximum concentration of 33%, for about ninety days. No significant toxicologic differences were recorded between the animals consuming genetically modified and non-modified corn regarding nutritional, ophthalmic, clinic and neurobehavioral parameters, as well as differences in weight of their organs. According to the authors of the study, these results verify that event TC1507 is as safe and nutritional than the non-genetically modified corn. Parameters of health status and development were assessed in lactating cows fed with fodder and event TC1507 corn grains(31). No difference was reported between the group fed with fodder containing and non containing transgenic corn regarding milk production and composition, as well as regarding parameters of health status (physical measurements and blood tests). Poultry fed with fodder containing event TC1507 corn failed to display any difference regarding mortality and growth when compared with poultry fed with non-transgenic corn(32). Compositional analyses of event TC1507 corn were also conducted for macronutrients, minerals, vitamins, amino acid and fat acid profiles, antinutrients and secondary metabolites. Results were similar to the ones involving conventional corn and were recorded in tiers described in the literature(33, 34, 30). Additionally, a study of acute oral toxicity was conducted in male and female CD1 mice, which received 5.050 mg/kg of protein Cry1F through gastric intubation(35). There was no mortality, clinic signs of toxicity, effects on animal growth and macroscopic lesion in organs, and therefore oral LD50 was assumed to be higher than 5.050 mg/kg. The PAT protein was degraded by gastric juice of animals and by artificial human gastric juice, losing its physicochemical characteristics after oral exposure. Therefore, it is not expected the protein to be fully absorbed, making unlikely that it may have adverse or toxic effects. Innocuousness of the transformation by pat gene is verified in works developed by different research teams. A study conducted with cows fed with fodder formulated with isogenic and transgenic corn for this modification, showed the similarity in yield and composition of milk produced by both groups of animals(36). The same work also analyzed the appearance of transgene fragments in 90 milk samples along the experimental period, with no positive result of transposing natural barriers or appearance of DNA fragments or its corresponding protein in the milk. A detailed study on PAT protein innocuousness was conducted approaching structural assessment, research of glycosylation sites, thermal stability and in vitro digestibility. The protein expressed by gene pat was analyzed, and the conclusion was for the safety of its use in plant modifications under all the investigated aspects(37). These results enable, in addition, an inference that the PAT protein fails to present any characteristics of allergenicity to sensitive individuals, either by direct action or by crossed reaction with other allergenic molecules. Allergens originated from food are commonly resistant to heat, acid and proteases, may be glycosed and are present in high concentrations. Proteins essayed are readily digested by gastric juice, are not glycosylated and the heating leads to bioactivity loss. Experiments conducted with animals failed to indicate any allergenic potential. No significant similarity was recorded between the Cry1F protein and dermal, respiratory and food allergens. Besides, the protein, coming from a non-allergenic source, is thermolabile, rapidly hydrolyzed when submitted to in vitro essay of resistance to pepsin, being not glycosylated(38, 39). The data, simultaneously analyzed, indicate lack of Cry1F allergenic potential(39). This conclusion was reached by Hérouet et al.(37) regarding PAT, after different analyses conducted with the protein. The authors recorded that the protein sequence did not display homology with known allergens or toxins. Besides, PAT has no N-glycosylation site, is rapidly degraded by gastric and intestinal fluids and has a source held as innocuous. Similar results have been described in other studies(40, 38). Corn and its derivatives are not considered toxic. The genetic modification of TC507 corn lineage results from the expression of Cry1F and PAT proteins. Protein Cry1F displays specific toxicity against certain Lepidoptera plague insects (target organisms), however there is no evidence that Cry proteins generated from Bacillus thuringiensis may harm human and animal health(41, 42). The potential toxicity for humans and animals of protein Cry1F was examined in an acute oral toxicological study where acute toxicity potential in rats(35) of the Cry1F delta-endotoxin of B. thuringiensis var. aizawai was assessed. The highest dose used in the essay was 5050 mg/kg LW, adjusting the purity of the essayed material (11.4%), the dose was 576 mg Cry1F/kg of body weight. In the course of the study, notes were taken on mortality, clinical pathology and behavioral symptoms, as well as on body weights, performing full necropsies at the end of the study. No mortality was recorded in the course of the study. During the experiment, no adverse clinical signs were present, and no adverse results were recorded in the necropsies. Changes in the dose used in this study failed to provoke mortality among individuals submitted to the essay, and therefore it was not possible to determine the LD50 of the Cry1F protein. In another oral acute toxicity study, rats were fed with 6000 mg/kg of an essay material containing about 500 mg of protein PAT/kg LW(43). No clinical observations were produced related to the treatment. All rats gained weight during the two weeks of observation and none displayed pathologic lesions. In study conditions, and due to absence of any observable toxicity, determination of PAT protein LD50 was not possible. PAT protein toxicity safety was determined in detail during the evaluation of glufosinate ammonium tolerant corn(41, 44, 45, 46, 47). Gene pat was originally obtained from strain Tü494 of bacterium Streptomyces viridochromogenes that does not have known toxic or pathogenic potential. PAT protein is enzymatically active. However, it displays high specificity for a substratum that does not exist in corn plants or in human and animal diets. A study was conducted on feeding chicken through incorporation to the diet of TC1507 corn lineage grains and non-transgenic control grains of comparable germplasm(48). Mortality, weight gain and alimentary conversion of chicken fed on a diet containing grain from corn TC1507 lineage were compared with chicken fed on a standard diet containing common corn. No significant statistical difference in mortality, weight gain and alimentary conversion was recorded between chicken feeding on the TC1507 corn and those on the control diet. When assessing the allergenic potential, the most important issue to consider is the biologic origin of the gene introduced and whether it expresses the allergenic product(49). Both, Bacillus thuringiensis (origin of the cry1F gene) and Streptomyces viridochromogenes (origin of the pat gene) have no history of allergy triggering factors. These donors are common soil bacteria. In over 30 years of commercial use, there was no verifiable information of Bacillus thuringiensis allergenicity, including occupational allergies related to the manufacture of products containing it(41). The biochemical profile of proteins Cry1F and PAT provide the background for an allergenic assessment by comparing them with allergens of known proteins. Comparison of amino acid sequences of an introduced protein with amino acid sequences of known allergens may result in a useful indicator of allergenic potential(50). Meyer(38) conducted a search assisted by the Wisconsin Genetics Computer Group (GCG) sequence analyzer computer program, looking up for “allergenic” in the database of standard DNA and protein sequences. A significant homology is the one recording a sequence identity of 8 or more contiguous amino acids. A comparison of the 15 sequences of the most homologous data bases confirmed that protein Cry1F does not share a significant amino acid sequence homology with known allergenic proteins. In a similar way, PAT protein amino acid sequences were compared with allergens of known proteins(38). The comparison showed that the PAT protein does not share significant amino acid homology with known allergenic proteins. The PAT protein had already been assessed for previous safety of genetically modified plants(41, 44, 45, 46, 47), including commercial release proceedings passed by CTNBio. Allergens in food proteins are generally stable in digestion by pepsin and trypsin and in acid conditions of the human digestive tract, so that they may pass through the intestinal mucosa to generate an allergenic response. Both Cry1F and PAT proteins are easily degradable in simulated digestive fluid, minimizing any potential the proteins may have of being absorbed by the intestinal mucosa when consumed. After one minute, protein Cry1F is almost completely hydrolyzed in simulated gastric conditions at a 100:1 molar reaction (Cry1F:pepsin)(51). The immunoelectrotransfer blot detection technique also showed that protein Cry1F is not glycosylated. On the other hand, protein Cry1F loses immunoreactivity after being processed by heat and has not history of harmful use in microbial pesticides. The PAT protein was degraded to undetectable levels within 5 seconds from introduction of a simulated gastric fluid containing pepsin (40,47). Therefore, genes cry1F and pat introduced in the TC1507 corn lineage do not code known allergens and both proteins, Cry1F and PAT, do not share immunologically significant amino acid sequences with known allergens. These results, coupled with the rapid rupture of the proteins under digestive conditions, confirm that Cry1F and PAT proteins are unlikely to pose any significant allergenic risk. Corn is extensively cultivated and has a history of safe use as human and animal food. Corn is not considered to be harmful to humans, domestic animals and the wild fauna. With the exception of the new characteristics introduced, including resistance to certain Lepidoptera pests granted by gene cry1F and tolerance to glufosinate ammonium granted by gene pat, the TC1507 corn lineage is substantially equivalent to other corn lineages commercially found. No other characteristic of the original organism was modified that may be harmful or pose a risk to health. No adverse effects were recorded in TC1507 corn lineage to human health and the environment. V. Environmental and Agronomic Aspects Corn is an annual plant with low dormancy ability. The corn seed can survive from one cultivation season to another, and may successfully germinate under adequate temperature and moist conditions. These so-called volunteer plants are easily identified and controlled by manual, mechanical and chemical means. Corn does not exhibit tendency to proliferate as a plant pest and is not invasive in natural ecosystems(45). Some species of the Zea genus are sylvan plants developing successfully in Central America without any considerable trend to proliferate as a plant pest. Event TC1507 was carefully cultivated and monitored in what regards its proliferation ability as plant pest and agronomic behavior in over eighty locations around the world, including Argentina, United States, Chile, Italy, Brazil, France and South Africa. In Brazil, several planned releases to the environment were presented by applicants and duly passed by CTNBio. In all cases, TC1507 corn exhibited a behavior similar to the one expected from non-transgenic corn, without evidencing any development of unforeseen morphologic or phenotypic characteristics. In experimental and field essays conducted in Brazil by Dow AgroSciences during the 2005-2006 crops to compare TC1507 corn with the conventional material, several agronomic parameters were measured, such as: plant height, ear, stalk breaking, root size and yield, among other agronomic characteristics and resistance to diseases. Results reached in experiments conducted in domestic soil were comparable to those attained in Argentina and United States, where it was demonstrated that the genetic modification does not affect the plant phenotype and field behavior. Experimental essays conducted all over the world with TC1507 corn lineage since 1997 confirmed that event TC1507 does not show any unexpected change in plant vigor. Assessment by simple observation of field essays showed that the development from an emerging plantlet to one-leaved plantlet, and from three to five leaves plantlet, TC1507 corn lineage is comparable to the non-genetically modified corn. Applicants additionally conducted field essays in Brazil, where resistance to common rust (Puccinia sorghi), Polysora rust (Puccinia Polysora), cercosporiosis (Cercospora zea-maydis), Northern corn leaf blight (Exserohilum turcicum), Phaeosphaeria leaf spot (Phaeosphaeria maydis), and Diplodia leaf spot (Diplodia macrospora) was assessed. The data indicate that in the four hybrid essayed there was no differences in disease severity between the hybrid with TC1507 event and the correspondent conventional hybrid. Comparatively, essays were conducted to assess resistance characteristics of hybrids derived from TC1507 corn lineage and their corresponding non-genetically modified corn to diseases such as Exserohilum turcicum leaf spot, Bipolaris maydis leaf spot, Polysora rust, cercosporiosis, Erwinia stewartii bacterial spot, Ustilago zeae smut and resistance to pests, such as armyworm Spodoptera frugiperda, corn earworm Helicoverpa zea, Frankliniella sp. thrips, Aphis sp. aphis, Chaetocnema pulicaria corn flea beetle, red acarus, among others. These essays showed that there was no difference to be recorded on severity of disease symptoms; damage caused by insects, except for organisms identified as susceptible to protein Cry1F among plants of event TC1507 and those of genetically modified corn. The biological activity of protein Cry1F was studied in a range of pest insects feeding on corn plants. The essays were conducted by exposing insects to artificial diets treated with aqueous formulations of Cry1F protein produced from a microbial source (P. fluorescens). Evans(51) showed that the biochemical characteristics of a protein produced in either plant or microbial form are equivalent. Insects studied were: armyworm (Spodoptera Frugiperda), moth borer (Diatraea saccharalis), European corn borer (Ostrinia nubialis), corn earworm (Helicoverpa zea), black cutworm (Agrotis ipsilon), lesser cornstalk borer (Elasmopalpus lignosellus), Southwest corn borer (Diatraea grandiosella), Western corn rootworm (Diabrotica virgifera virgifera), corn leaf aphid (Rhopalosiphum maidis) and corn leafhopper (Dalbulus maidis). Huang et al.(55) have already assessed Cry proteins specificity through essays in connection with cell vesicles, evidencing the high specificity of this protein complex to insect receptors. Efficacy essay was conducted in the cities of Itumbiara, (GO), Toledo (PR), Indianápolis (MG), and Jardinópolis (SP) during the 2005 calendar year. Experiments were conducted according to cultural practices recommended for each region. In that same year, a first assessment was made, including incidence of initial pests and predators. Incidence of the lesser cornstalk borer, Elasmopalpus lignoselus (Zeller), was not recorded in any of the localities. Pooled variance analysis of data in the four localities revealed significant difference among the three treatments studied: conventional Pioneer P30F33 corn with application of insecticide, conventional Pioneer P30F33 corn without application of insecticide, and the same hybrid P30F33 – 1507 (Bt), using F test. Analysis of data related to assessment of herbivory and incidence of green stink bug, based on the percentage of plants with damage symptoms, revealed that interaction site x treatment was significant. The result showing the comparison of averages for herbivory is lower for the P30F33 – TC1507 in each site. Currently there is an indiscriminate use of insecticides in Brazil, including a mix of chemical products, in an attempt to control insects, especially S frugiperda. With the massive employment of these chemical products an agricultural desert is created in certain Brazilian regions, since the natural enemies of such pests are the first to be eliminated. Frequent employment of chemical insecticides contributes to environmental degradation, pollution and an environmental breakdown in corn culture and even in other rotation crops. By adopting insect resistant genetically modified plants, reduction in insecticides has been considerable in countries where this technology has been adopted for over ten year. In the United States, for instance, farmers have obtained reductions of over 8,000 tons of active insecticide ingredient in 2001 alone(52, 53, 54). In China, the employment of insecticides were reduced 67% on average, and reduction in volume of active insecticide ingredient reached 80%(55). In South Africa, the reduction was around 66%(56). For the foregoing, one may argue that the use of the Bt technology in Brazil may contribute towards a reduced employment of insecticides and, consequently, mitigating the impacts to the environment and human and animal health resulting from the use of these pesticides. Furthermore, the use of Bt technologies may positively affect the preservation of non-target populations and beneficial insects, facilitating an integrated management of farm pests(57, 55, 58). In addition, adoption of technologies that minimize the spraying of chemical products in crops may bring secondary benefits such as reduced use of inputs in the production of pesticides, conservation of fuels used to produce, distribute and apply the pesticides and elimination of the need for use and discard of pesticide packing. VI. Restrictions to the use of the GMO and its derivatives. Studies submitted by applicant showed that there was no significant difference between corn hybrids derived from non-modified lineages and TC1507 corn regarding agronomic characteristics such as productivity, moist at harvest, root bedding and plant height, among others. Besides, there was no significant differences in the method of reproduction, dissemination and survival ability of the genetically modified corn compared with non-modified lineages. All evidences submitted in the proceedings and bibliographic references(60, 61, 62, 63, 64, 65, 66) confirm the risk level of the transgenic variety as equivalent to those of non-transgenic in what regards soil microbiota, non-target vertebrate and invertebrate animals, other plants and human and animal health. Therefore, cultivation of TC1507 corn is not potentially a cause of significant degradation of the environment and of risks to human and animal health. For the foregoing, there is no restrictions to the use of this corn and its derivatives. After being used for ten years in different countries, there was no record of problem to human and animal health or to the environment that may be attributable to transgenic corns. It is worth emphasizing that absence of negative effects resulting from cultivation of transgenic corn plants does not imply that they may not happen in the future. Zero risk coupled with absolute safety does not exist in the biologic world, although there is a host of trustworthy scientific information and a safe use history of ten years that enables us to say that TC1507 corn is as safe as conventional corn versions. This way, applicant shall conduct a post-commercial release monitoring according to the provisions of CTNBio Ruling Resolution no. 03. The vertical genic flow to local varieties, the so-called Creole corns, of open pollination is possible and displays the same risk caused by commercial genotypes available in the market (80% of conventional corn planted in Brazil comes from commercial seed that underwent a process of genetic improvement. Coexistence between cultivars of conventional corns (improved or Creole) and transgenic corn cultivars is possible from the agronomic viewpoint(43, 67) and shall follow the provisions of CTNBio Ruling Resolution no. 4. VII. Considerations about Particulars of Different Regions in the Country (subsidy to monitoring agencies): According to Article 1 of Law no. 11,460, of March 21, 2007 ”research and cultivation of genetically modified organisms may not be conducted in Amerindian areas and conservation units”. VIII. Conclusion Considering that TC1507 corn is derived from a transformation of common Zea mays corn, a fully characterized species with a solid history of safety for human and animal consumption; that the transformation process caused insertion of a single copy of a DNA fragment containing genetic constructs with pat and cry1f genes. Considering that safety of corn containing the pat gene was exhaustively assessed by CTNBio in proceedings 01200.005154/1998-36, and analyzed corn containing genes cry1A(b) and pat in proceedings 01200.002109/2000-04; and that all aspects regarding corn biosafety were studied for corns Liberty Link and Bt11 in Technical Opinions no. 987/2007 and 1255/2008. Whereas: 1. Corn is the species that reached the highest domestication level among cultivated plants, and is unable to survive in nature with no human intervention. 2. In Brazil, there are no wild species with which corn may intercross, since the closest wild corn species is teosinte, found only in Mexico and in some Central America locations, where it may cross with corn cultivated in production fields. 3. Protein Cry1F was detected in low levels in tissues analyzed and displayed high susceptibility to digestion in simulated gastric fluids, failing to show acute toxicity in mammals and similarity with known allergens(38). 4. The DNA molecule is a natural component of food and there is no evidence that this molecule may have adverse effect to man when ingested in food in acceptable amounts. 5. There is no evidence that intact genes of plants may be transferred and functionally integrated to the human genome or genome of other mammals exposed to such DNA or to foods manufactured with such elements(50). 6. Applicant answered to all questions mentioned in CTNBio Ruling Instruction no. 05 and there is no issue indicating that this corn may present adverse effects to human and animal health. 7. There is no likelihood that TC1507 corn may perform or cause invasion of uncultivated areas. 8. Proteins Cry1F and PAT are rapidly degraded in gastric conditions, thus minimizing any absorption potential in an intestinal system(51, 40). 9. Bacterium B. thuringiensis may be considered the most potent biological agent to control forest and agricultural pest insects and disease vectors for the specificity of delta-endotoxins to insects and target-invertebrates, and its innocuousness to vertebrates and the environment, including beneficial insects and natural enemies, making this agent a key component in integrated management of pests. 10. Cultures of B. thuringiensis are filed with Agência Nacional de Vigilância Sanitária – ANVISA, the National Sanitary Surveillance Agency, under different formulations for application in thirty types of plant cultures for food use(68). 11. Biopesticides based on such toxin are widely used as an alternative to chemical insecticides in terms of safety to non-target organisms and when development of resistance to chemical insecticides is the case(69). 12. The use of Bt technology in Brazil may contribute to reduce the use of insecticides and, consequently, mitigate the impact resulting from the use of such pesticides to the environment, human and animal health, and to positively affect the preservation of non-target organisms and beneficial insects, facilitating the integrated management of farm pests. 13. This corn variety shows low risk to human health, animal health and is no likely to change into a plant pest. 14. The gene insertion did not change the composition and nutritive value and the presence of protein Cry1F in proportion to the total corn protein does not imply significant contribution to the amount or proteins in human diet. 15. Nutritional, equivalence and toxicological tests have been reported showing the expressed protein to be innocuous(26, 27, 28). 16. Concurrently to resistance to insects, the Bt toxin contributes to reduce mold development in corn ears, which are responsible for production and contamination of corn with mycotoxins(29). 17. No other characteristic of the original organisms that represents risks to human health was modified and there was no record of adverse effects resulting from TC1507 corn in studies related to human health and the environment. 18. Commercial use of TC1507 corn lineage is occurring in the United States since 2001, Argentina (2005), Colombia (2006), China (2004), Mexico (2003), South Africa (2002), Canada (2002), Australia (2003), Japan (2002), Korea (2002), Philippines (2003), Taiwan (2003) and European Union (2006) without any record of problems linked to the agronomic characteristics of the event. 19. Comments, opinions, suggestions and documents resulting from a Public Hearing related to TC1507 corn held on March 20, 2007, failed to register any relevant scientific fact, corroborated by scientific evidence, that may compromise the environmental safety and human and animal health. 20. Coexistence of conventional corn cultivars (improved or Creole) and transgenic cultivars is possible from the agronomic viewpoint, and the provisions of CTNBio Ruling Instruction no. 04 shall be complied with. For the foregoing, and considering internationally accepted criteria in the process of risk analysis for genetically modified raw-materials, a conclusion emerges that TC1507 corn is as safe as its conventional equivalent. CTNBio holds that commercial cultivation and consumption of TC1507 corn are not potential causes of significant degradation to the environment or of harm to human and animal health. Restrictions to the use of the GMO analyzed and its derivatives are conditioned to the provisions of CTNBio Ruling Resolutions no. 03 and 04. Additionally, this risk analysis took into consideration and consulted third party independent studies and scientific publication submitted by applicant. IX. Bibliography 1. Watson Leslie. Dallwitz, Michael J. The grass genera of world. C.A.B. International. Wallingford, OX. c1992. 2. KIESSELBACH T.A. The structure and reproduction of corn. Lincoln : University of Nebraska, 1980. 96p. 3. BAHIA FILHO A.F.C.; GARCIA J.C. 2000. Análise e avaliação do mercado brasileiro de sementes de milho. In: UDRY C.V.; DUARTE W.F. (Org.) Uma história brasileira do milho: o valor de recursos genéticos. Brasília: Paralelo 15, 167-172. 4. FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS – FAO. 2007. FAOSTAT. Available at: http://faostat.fao.org/site/340/default.aspx. 5. Companhia Nacional de Abastecimento – CONAB. 2007. Milho total (1ª e 2ª safra) Brasil – Série histórica de área plantada: safra 1976-77 a 2007-07. http://www.conav.gov.br/conabweb/download/safra/MilhoTotalSerieHist.xls 6. CRUZ I.; FIGUEIREDO M.L.C.; OLIVEIRA A.C.; VASCONCELOS C.A. 1999. Damage of Spodoptera frugiperda (Smith) in different maize genotypes cultivated in soil under three levels of aluminium saturation. International Journal of Pest Management 45:293-296. 7. WAQUIL J.M.; VILLELA F.M.F.; FOSTES J.E. 2002. Resistência do milho ( Zea mays L.) transgênico ( Bt) à lagarta-do-cartucho, Spodoptera frugiperda (Smith) ( Lepidoptera: Noctuidae). Revista Brasileira de Milho e Sorgo 1(3): 1-11. 8. AGBIOS, Information on GM Approved Products. http://www.agbios.com/dbase,hph (available on 12/05/2008). 2008 9. ALVES FILHO J.P. 2001. Agrotóxicos e Agenda 21: sinais e desafios da transição para uma agricultura sustentável. In: II SINTAG Anais. II Simpósio Internacional de Tecnologia de Aplicação de Agrotóxicos: Eficiência, Economia e Preservação da Saúde Humana e do Ambiente, Jundiaí, SP, 07/17/2001 a 07/20/2001. 10. Klein T.M., E.D. Wolf, R. Wu, and J.C. Sanford. 1987. High velocity microprojectiles for delivering nucleic acids into living cells. Nature 327: 70-73. 11. Narva K., Zeph L., and Jayne S.; 1998. Product characterization data for Bacillus thurigiensis var. aizawai Cry1F insect control protein as expressed in maize. An unpublished technical report by Mycogen c/o Dow AgroSciences LCC. 12. CRICKMORE N. 2007. Bacillus thuringiensis Toxin Nomenclature. http://www.lifesci.sussex.ac.uk/home/Neil_Crickmore/Bt/ available on 12/05/2008. 13. MONNERAT R.G.; BRAVO A. 2000. Proteínas bioinseticidas produzidas pela bacteria Bacillus thuringiensis: modo de ação e resistência. In: MELLO I.S.; AZEVEDO J.L. (ed.) 2000. Controle Biológico. Jaguariúna: Embrapa Meio Ambiente, 163-200. 14. De MAAGD R.A.; BRAVO A.; BERRY C. CRICKMORE N. SHNEPF H.E. 2003. Structure, diversity, and evolution of protein toxin from spore-forming entomapathogenic bacteria. Ann. Rev. Genet. 37: 409-433. 15. KRIEG A.; LANGENBRUCH G.A. 1981. Susceptibility of arthropod species to Bacillus thuringiensis. In: BURGES H.D. (Ed.) Microbial control of pests and plant diseases 1970-1980. London: Academic, 837-896. 16. Schenepf E., Crickmore N., Van Rie J.; Lereclus D.; Baum J.; Feitelson J.; Zeigler D. R., and Dean D.H. 1998 Bacillus thuringiensis and Its Pesticidal Crystal Proteins. Microbiol. Mol. Biol. Reviews. Sept, 1988. p. 775-806. 17. Van Wert, 1994. Petition for Determination of Nonregulated Satus: Glufosinate Resistant Corn Transformation Events T14 and T25. U.S. Department of Agriculture, Washington, DC. 18. FORLANI G.; OBJSKA A.; BERLICKI, £; KAFARSKI P. 2006. Phosphinothricin analogues as inhibitors of plant glutamine synthetases. J. Agric. Food Chem. 54: 796-806. 19. TAN S.; EVANS R.; SINGH B. 2006. Herbicidal inhibitors of amino acid biosynthesis and herbicide-tolerant crops. Amino Acids 30: 195-204. 20. YI G.; SHIN Y.M.; CHOE G.; SHIN B.; KIM Y.S.; K.M. 2007. Production of herbicide-resistant sweet potato plants transformed with the bar gene. Biotechnol. Lett. 29:669-675. 21. Alarcon C. and Marshall L. 200. Characterization of proteins as expressed in B.t. Cry1F maize tissues. Report number 99-023, an unpublished technical report by Pioneer Hi-Bred International, Inc. 22. Gao Y. Fencil K.J; Xu X.; Schwedler D.A.; Gilbert J.R & Herman R.D. Purification and Characterization of a Chimeric Cry1F-Endotoxin Expressed in Transgenic Cotton Plants. J. Agric. Food Chem. 2006, 54, 829-835. 23. FAO/WHO – Organización de las Naciones Unidas para la Agricultura y la Alimentación / Organización Mundial de la Salud. 2004. Codex Alimentarius: Alimentos obtenidos por medios biotecnológicos. Roma: FAO, 57pp. 24. McClintock, JT, Schaffer CR, Sjoblad RD. A comparative review of the mammalian toxicity of Bacillus thuringiensis-based pesticides. Pestic Sci, 45: 95-105, 1995. 25. Mendelsohn M, Kough J, Vaituzis Z, Matthews K. Are Bt crops safe? Nat Biotechnol, 21: 1003-9, 2003. 26. Bets FS, Hammond BG, Fuchs R.L. Safety and advantages of Bacillus thuringiensis-protected plants to control insect pests. Regul Toxicol Pharmacol. 32(2):156-73,2000. 27. Aumaitre A.; Aulrich K.; Chesson A.; Flachowsky, G.; Piva G. New feeds from genetically modified plants: substantial equivalence, nutritional equivalence, digestibility, and safety for animals and the food chain. Livestock Prod. Sci., v.74, p.223-238, 2002. 28. Herman R.A.; Phillips A.M.; Collin R.A.; Tagliani L.A.; Claussen F.A.; Graham C.D.; Bickers B.L.; Harris T.A.; Prochaska L.M. Compositional equivalency of Cry1F corn event TC6275 and conventional corn (Zea mays L.). J. Agric. Food Chem. 52, 2726-2734, 2004. 29. Williams W.P.; Windham G.L.; Buchley, P.M.; Perkins, J.M. Southwestern corn borer damage and aflatoxin accumulation in conventional and transgenic corn hybrids. Fields Crop. Res.; v.91, p.239-336, 2005. 30. Mackenzie S.A.; Lamb I.; Schmidt J.; Deege L.; Morrisey M.J.; Harper M.; Layton R.J.; Prochaska L.M.; Sanders C.; Locke M.; Mattsson J.L.; Fuentes A.; Delaney B. 2007. Thirteen week feeding study with transgenic maize grain containing event DAS-01507-1 in Sprague-Dawley rats. Food Chem. Toxicol., v.45, p.551-562. 31. Faust M, Smith B, Rive D, Owens F, Hinds M, Dana G, Hunst P. 2007. Performance of lactating dairy cows fed silage and grain from a maize hybrid with the cry1F trait versus its nonbiotech counterpart. J Dairy Sci, 90:5706-13. 32. Zeph L. Nutritional equivalence of B.t. Cry1F maize – poultry feeding study. Pioneer Hi-Bred International, Inc., Johnston, Iowa. Study number PHI99-010, 2000. 33. Stauffer C. and Zeph L. 2000. Compositional Analysis of Maize MPS Hybrid Line 1507. Report number PHI98-012, an unpublished technical report by pioneer Hi-Bred International, Inc. 34. Stauffer C. 2000. Quantitative ELISA Analysis of poCry1F and PAT Protein Expression Levels, Compositon and Efficacy of Hybrid Lines 1360 and 1507 – EU Field Sites. Report number PHI99-005, an unpublished technical report by Pioneer Hi-Bred International, Inc. 35. KUHN J.O. Cry1F Bt var. aizawai Delta-endoprotein: Acute Oral Toxicity Study in Mice (Delta-endoproteina Cry1F de lar var. azawai del Bt: Estudio de toxicidad aguda oral em ratones). Report number 42-81-98, an unpublished technical report by Mycogen Seeds c/o Dow AgroSciencies LCC. 1998. 36. Phipps R.H.; Jones A.K.; Tingey A.P.; Abeyasekera S.2005. Effect of corn silage from an herbicide-tolerant genetically modified variety on milk production and absence of transgenic DNA in milk. J. Dairy Sci. v.88, p. 2670-2978. 37. Herouet C, Esdaile DJ, Mallyin BA, Debruyne E, Schulz A, Currier T, Hendrickx K, van der Klis RJ, Rouan D. Safety evaluation of the phosphinothricin acetyltransferese proteins encoded by the pat and bar sequences that confer tolerance to glufosinate-ammonium herbicide in transgenic plants. Regul Toxicol Pharmacol. 41(2):134-49, 2005. 38. Meyer T. 1999. Comparison of Amino Acid Sequence Similarity of Cry1F and PAT Proteins to Known Allergen Proteins (Comparación de la similitud de la secuencia de aminoácidos de las proteínas Cry1F PAT con proteínas alérgenas conocidas). Report number PHI99-013, an unpublished technical report by Pioneer Hi-Bred International, Inc. 39. Ladics GS, Bardina L, Cressman RF, Mattsson JL, Sampson HA. Lack of cross-reactivity between the Bacillus Thuringiensis derived protein Cry1F in maize grain and dust mite Der p7 protein with human sera positive for Der p7-IgE. Regul Toxicol Pharmcol, 44:136-43,2006. 40. GLATT C.M. Phosphinothricin acetyltranferase (PAT) protein: In Vitro Digestibility Study, Report number DuPont 3365, an unpublished technical report by E.I. du Pont de Nemours an Company, 1999. 41. EPA. 1995a. Plant Pesticide Bacillus thuringiensis CryIIIa delta-endotoxin and the genetic material necessary for its production; tolerance exemption. Fed. Reg. PP3F4273/R2132; FRL-4953-2. 42. EPA.1996.a, Bacillus thuringiensis CryIA(b) delta-endotoxin and the genetic material necessary for its production in all plants; exemption from requirement of a tolerance Fed. Reg., 61,150, pp. 40340-40343. 43. BROOKS K.J. PAT microbial protein (FL): Acute Oral Toxicity Study in Cd-1 Mice. Report number 991249, an unpublished technical report by Micogen c/o Dow AgroSciences LLC. 2000. 44. EPA 1997. Phosphinothricin Acetyltranferase and the Genetic Material Necessary for its Production in All Plants; Exemption from the Requirement of a Tolerance On All Plants; Exemption from the Requirement of a Tolerance On All Raw Agricultural Commodities. Fed. Reg. 62:17717-17720. 45. CFIA.1994. Regulatory Directive Dir94-11: The Biology of Zea mays L. (Corn / Maize). Canadian Food Inspection Agency, Plant Products Division, Plant Biotechnology Office, Ottawa. 46. SCP 1998. Opinion of the Scientific Committee on Plants regarding submission for placing on the market of glufosinate tolerant corns (Zea mays) transformation event T25by the AgEvo Company (Notification C/F/95/12/07). 47. OECD. 1999. Consensus document on general information concerning the genes and their enzymes that confer tolerance to phosphinothricin herbicide. Series on Harmonization of Regulatory Oversight in Biotechonoly No.11. 48. Zeph L. Nutritional equivalence of B.t. Cry1F maize – poultry feeding study. Pioneer Hi-Bred International, Inc., Johnston, Iowa. Study number PHI99-010, 2000. 49. FDA (Food and Drug Administration). 1992. U. S. Food and Drug Administration. Statement of Policy: foods derived from new plant varieties. Fed. Ref. (USA) 57:22984-23005. 50. FAO/WHO – Food and Agriculture Organization of the United Nations. 2000. Safety Aspects of Genetically Modified Foods of Plant Origin. Report of Joint FAO/WHO Expert Consultation on Foods Derived from Biotechnology, 29 May – 2 June 2000. World Health Organization, WHO Headquarters, Geneva, Switzerland. 35pp. http://www.who.int/foodsafety/publications/biotech/en/ec_june2000_en.pdf. (Available on 15/05/2008). 51. EVANS S.L. Equivalency of Microbial and Maize Expressed Cry1F Protein; Characterization of Test Substances for Biochemical and Toxicological Studies. Report number MYCO98-001, an unpublished technical report by Mycogen Seeds c/ o Dow AgroSciences, 1998. 52. CARPENTER J.; FELSOT A; GOODE T.; HAMMING M.; ONSTAD D.; SANKULA S. 2002. Comparative environmental impacts of biotechnology-derived and traditional soybean, corn, and cotton crops (CAST: 1-189). Ames, IA: Council for Agricultural Science and Technology. 53. EDGE J.M.; BENEDICT J.H.; CARROLL J.P.; REDING H.K. 2001. Bollgard Cotton: An assessment of global economic, environmental and social benefits. J. Cotton Sci 5: 121-136. 54. GIANESSI L.; SILVERS C.; SANKULA S.; CARPENTER J.A. 2002. Plant biotechnology: current and potential impact for improving pest management in U.S. agriculture – an analysis of 40 case studies (executive summary). Washington, DC: National Center for Food and Agricultural Policy. http://www.ncfap.org/40CaseStudies/NCFAV%20Exec%20Sum.pdf 55. HUANG J.; ROZELLE S.; PRAY C.; WANG Q. 2002. Plant biotechnology in China. Science 295:674-676. 56. ISMAEL Y.; BENNETT R.; MORSE S. 2002. Bt cotton, pesticides, labour and health: a case study of smallholder farmers in the Makhatini Flats, republic of South Africa. Paper presented at the 6th International ICABR Conference, Ravellho, Italy. 57. XIA, JY.; CUI J.J.; MA L.H.; DONG S.X.; CUI X.F. 1999. The role of transgenic Bt cotton in integrated insect pest management. Ata Gossypii Sim 11: 57-64. 58. BENEDICT J.; ALTMAN D. 2001. Commercialization of transgenic cotton expressing insecticidal crystal protein. In: JENKINS J.; SAHA S. ( eds). Genetic improvement of cotton: emerging technologies. Enfield: Science Publishers, 137-201. 59. LEONARD R.; SMITH R. 2001. IPM and environmental impacts of bt cotton: a new era of crop protection and consumer benefits. ISN N° 00401074. 60. SHULER T.H.; DENHOLM I.; JOUANIN L.; CLARK S.J.; CARK A.J. POPPY G.M. 2001. Populations-scale laboratory studies of the effect of transgenic plants on nontarget insects. Mol. Ecol. 10: 1845-1853. 61. DE MAAGD R.A.; BRAVO A,. CRICKMORE N. 2001. How Bacillus thuringiensis has evolved specific toxins to colonize insect world. Trends Genet. 17: 193-199. 62. CANDAS M.; LOSEVA O.; OPPERT B.; KOSARAJU P.; BULLA JUNIOR L.A. 2003. Insect resistance to Bacillus thuringiensis: alterations in the indianmeal moth larval gut proteome. Molec, Cel, Proteomics 2.1: 19-28. 63. BROOKES G.; BARFOOT P.; MELÉ E.; MESSEGUER J.; BÉNÉTRIX F. BLOC D.; FOUEILLASSAR X; FABIÉ A.; POEYDOMENGE C. 2004. Genetically modified maize: pollen movement and crop coexistence. Dorchester UK: PG Economics, 20pp. (www.pgeconomics.co.uk/pdf/Maizepollennov2004.final.pdf) 64. BRODERICK N.A.; RAFFA K.F.; HANDELSMAN J. 2006. Midgut bacteria required for Bacillus thuringiensis insecticidal activity. Proc. Natl. Acad. Sci. USA 103:15196-15199. 65. SANDEN M.; BERNTSSEN M.H.G.; KROGDAHL D.; HERME G-I.; MCKELLEP A-M. 2005. An examination of the intestinal tract of Atlantic salmon, Salmo salar L.; parrfed different varieties of soy and maize. J. Fish Dis. 28:317-30. 66. OKUNUKI H.; TESHIMA R.; SHIGETA T.; SAKUSHIMA J.; AKIYAMA H.; GODA Y., TOYODA M.; SAWADA J. 2002 Increased digestibility of two products in genetically modified food (CP4-EPSPS an Cry1Ab) after preheating. Shokuhin Eiseigaku Zasshi 43:68-73. 67. MESSEGUER J.; PEÑAS G.; BALLESTER J.; BAS M.; SERRA J.; SALVIA J.; PALAUDEMÀS M.; MELÉ E. 2006. Pollen-mediated gene flow in maize in real situations of coexistence. Plant Biotecnology Journal. 4:633-645. 68. Agencia Nacional de Vigilância Sanitária – ANVISA. 2006. http://www.anvisa.gov.br/toxicologia/monogradias/b01.pdf., Available on 10/15/2006. 69. RODRIGO-SIMÓN A.; DE MAAGD R.A.; AVILLA C.; BAKKER P.L.; MOLTHOFF J.; GONZÁLEX-XAMORA J.E.; FERRÉ, J.2006. Lack of detrimental effects of Bacillus thuringiensis Cry toxins on insect predator Chrysoperla carnea: a toxicological, histopathological, and biochemical analysis. Appl. Environ. Microbiol. 72: 1595-1603
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
MOlecular Traditional Methods
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: National Biosafety Commission
Upload:
Authorization expiration date (a blank field means there is no expiration date) Not Applicable
E-mail:
Organization/agency name (Full name):
National Biosafety Technical Commission
Contact person name:
Paulo Augusto Viana Barroso
Website:
Physical full address:
SPO Area 5 Qd 3 Bl B S 10.1 Brasilia DF
Phone number:
556120335087
Fax number:
Country introduction:

Brazil had the first biosafety law approved in 1995. After the identification of the need to improve the biosafety system of Brazilian genetically modified organisms, a new law was published. The Law 11.105 / 05 establishes a technical committee dedicated to the analysis of the safety aspects of genetically modified organisms and a council of ministers that is dedicated to the analysis of the socioeconomic aspects of the commercial release of genetically modified organisms. In this context, Brazil already has several commercial products that involve genetically modified organisms (plants, human and veterinary vaccines, microorganisms for fuel production) and products derived from new genetic modification techniques.

Useful links
Relevant documents
Stacked events:

At the discretion of, and upon consultation with, CTNBio, a new analysis and issuance of technical opinion may be released on GMOs containing more than one event, combined through classic genetic improvement and which have been previously approved for commercial release by CTNBio

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Dr. Paulo Augusto Viana Barroso (President of national Biosafety Commission)

Canada
Name of product applicant: Dow AgroSciences Canada Inc.
Summary of application:
Dow Agrosciences Canada Inc. developed Maize line 1507 through genetic modification to be tolerant to glufosinate-ammonium herbicides and protect the plant from certain lepidopteran larvae (including European corn borer, southwestern corn borer, fall armyworm, and black cutworm). The modified corn line permits farmers to use the herbicide for weed control and prevents loss in crop production due to the damaging insect pests.

Upload:
Date of authorization: 11/10/2002
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): BioTrack Product Database
Summary of the safety assessment (food safety):
Please see decision document weblinks
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: Novel Foods Decision
Novel Feeds Decision
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Health Canada
Contact person name:
Neil Strand
Website:
Physical full address:
251 Sir Frederick Banting Driveway, Tunney's Pasture, PL 2204A1
Phone number:
613-946-1317
Fax number:
Country introduction:

Federal responsibility for the regulations dealing with foods sold in Canada, including novel foods, is shared by Health Canada and the Canadian Food Inspection Agency (CFIA). Health Canada is responsible for establishing standards and policies governing the safety and nutritional quality of foods and developing labelling policies related to health and nutrition. The CFIA develops standards related to the packaging, labelling and advertising of foods, and handles all inspection and enforcement duties. The CFIA also has responsibility for the regulation of seeds, veterinary biologics, fertilizers and livestock feeds. More specifically, CFIA is responsible for the regulations and guidelines dealing with cultivating plants with novel traits and dealing with livestock feeds and for conducting the respective safety assessments, whereas Health Canada is responsible for the regulations and guidelines pertaining to novel foods and for conducting safety assessments of novel foods.

The mechanism by which Health Canada controls the sale of novel foods in Canada is the mandatory pre-market notification requirement as set out in Division 28 of Part B of the Food and Drug Regulations.

Manufacturers or importers are required under these regulations to submit information to Health Canada regarding the product in question so that a determination can be made with respect to the product's safety prior to sale. The safety criteria for the assessment of novel foods outlined in the current guidance document (i.e. Canadian Guidelines for the Safety Assessment of Novel Foods) were derived from internationally established scientific principles and guidelines developed through the work of the Organization for Economic Cooperation and Development (OECD), Food and Agriculture Organisation (FAO), World Health Organisation (WHO) and the Codex Alimentarius Commission. These guidelines provide for both the rigour and the flexibility required to determine the need for notification and to conduct the safety assessment of the broad range of food products being developed. This flexibility is needed to allow novel foods and food products to be assessed on a case-by-case basis and to take into consideration future scientific advances.

Useful links
Relevant documents
Stacked events:

Food: Consistent with the definition of "novel food" in Division 28 of the Food and Drug Regulations, the progeny derived from the conventional breeding of approved genetically modified plants (one or both parents are genetically modified) would not be classified as a novel food unless some form of novelty was introduced into such progeny as a result of the cross, hence triggering the requirement for pre-market notification under Division 28. For example, notification may be required for modifications observed in the progeny that result in a change of existing characteristics of the plant that places those characteristics outside of the accepted range, or, that introduce new characteristics not previously observed in that plant (e.g. a major change has occurred in the expression levels of traits when stacked). In addition, the use of a wild species (interspecific cross) not having a history of safe use in the food supply in the development of a new plant line may also require notification to Health Canada. However, molecular stacks are considered new events and are considered to be notifiable as per Division 28.

Feed:

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Neil Strand, Section Head of Novel Foods

China
Name of product applicant: Dupont China Holding Co.,LTd. and Dow Agrosciences China Ltd.
Summary of application:

Genetically modified organism: DAS-Ø15Ø7-1  (TC1507)  line of maize (Zea mays L.); Exogenous gene: cry1F gene, isolated from the common soil bacterium Bacillus thuringiensis and pat, isolated from the common aerobic soil actinomycete, Streptomyces viridochromogenes ;  Trait: Resistance to European corn borer (Ostrinia nubilalis); phosphinothricin (PPT) herbicide tolerance, specifically glufosinate ammonium; Transformation methods: Microparticle bombardment of plant cells or tissue; Safety level: Ⅰ

Upload:
Date of authorization: 06/04/2004
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): Center for Environmental Risk Assessment
Summary of the safety assessment (food safety):
Please see decision document uploaded
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Chinese Agriculture Department Announcement No. 869-7-2007: Detection of Genetically Modified Plants and Derived Products Qualitative PCR Method for Insect-Resistant and Herbicide-Tolerant Maize TC1507 and Its Derivates
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: Authority concern of GMO
Ministry of Agriculture of China
Upload:
Authorization expiration date (a blank field means there is no expiration date) 6/4/2007
E-mail:
Organization/agency name (Full name):
Development Center for Science and Technology, Min
Contact person name:
Fu Zhongwen
Website:
Physical full address:
Room 717, Nongfeng Building, No.96 Dong San Huan Nan Lu, Chaoyang District, Beijing, 100122, P. R. China
Phone number:
+86-10-59199389
Fax number:
+86-10-59199391
Country introduction:

Regulations on Safety of Agricultural Genetically Modified Organisms (hereafter referred to as the Regulations)was promulgated by Decree No. 304 of the State Council of the People’s Republic of China on May 23, 2001. Implementation Regulations on Safety Assessment of Agricultural Genetically Modified Organisms, Implementation Regulations on the Safety of Import of Agricultural Genetically Modified Organisms and Implementation Regulations on Labeling of Agricultural Genetically Modified Organisms are formulated by Ministry of Agriculture on January 5, 2002 in accordance with the Regulations. The State Council establishes a system of joint ministry conference for the safety administration of agricultural GMOs. The joint ministry conference for the safety administration of agricultural GMOs shall be composed of officials from relevant departments of agriculture, science and technology, environment protection, public health, foreign trade and economic cooperation, inspection and quarantine, and be responsible for the decision-making and coordination of major issues with respect to the safety administration of agricultural GMOs. According to Article 9 of the Regulations, a national biosafety committee (NBC) shall be established and in charge of safety assessment of agricultural GMOs. The NBC shall be composed of experts who are engaged in biological research, production, processing, inspection and quarantine with respect to agricultural GMOs, as well as experts in the fields of public health and environmental protection. The office term of the NBC shall be three years. Ministry of Agriculture is responsible for the nationwide supervision and administration of the safety of agricultural GMOs. The Ministry of Agriculture sets up an office for biosafety administration of agricultural GMOs(OBA), which will be in charge of the administration of the safety assessment of agricultural GMOs. OBA is Affiliated to the Department of Science, Technology and Education.

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

office for biosafety administration of agricultural GMOs(OBA), the Department of Science, Technology and Education,MOA, P. R. China Tel:+86-10-59193059, Fax:+86-10-59193072, E-mail: [email protected]

Indonesia
Name of product applicant: PT. DuPont Indonesia
Summary of application:

The genetically modified maize event TC1507 is resistant to insect of the Lepidoptera order and tolerant to glufosinate-ammonium herbicides.

Upload:
Date of authorization: 23/01/2015
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Please refer to the document (in Indonesian)
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Indonesian Agency for Agricultural Research and De
Contact person name:
Sustiprijatno
Website:
Physical full address:
BB Biogen Jl Tentara Pelajar 3A Bogor 16111 Indonesia
Phone number:
+622518333440
Fax number:
+622518334420
Country introduction:
  1. Indonesia has  ratified Protocol  on Biosafety to the  Convention on Biological Diversity (CBD) through the Indonesian Law No. 21 / 2004.  In the implementation, biosafety  assessment for GM products, based on Goverment Regulation Number 21 /2005, Indonesia  has regulated GM products on  several items including : product kinds and requrements, research and developement,  product importation,  product assessment, release and distribution, supervision and monitoring, and institution and financing. We have also Law for food  No. 18 /2012 which also consists of regulation for GM food.
  2. Indonesia already have procedure /application on GMO  biosafety assessment and National Authorized Institution who conducting  the biosafety  assessment .  Each GM food  should have authorization from Goverment  before it can be released and distributed. An application for authorisation for new  GM food  should be submited to  Biosafety Commision  through related Ministry or authorised Non Departement Goverment Agency (LPND) . Biosafety Commision, then sends the application to the National Agency for Drug and Food Control (Badan POM) for technical team to evaluate  the GM food safety.  The recommendation by technical team will be sent  back  to Biosafety Commision. The recommendation and GM Food safety certificate will be released by Biosafety Commision to the applicant through  related ministry or LPND.  
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

National Agency of Food and Drug Control (BPOM): http://www.pom.go.id/new/home/en

Iran
Name of product applicant: Dow AgroSciences
Summary of application:

Corn modified with the insertion of the Cry1F gene from Bacillus thuringiensis to confer resistance to the European corn borer (Ostrinia nubilalis). A transformation cassette coding for phosphinothricin (PPT) herbicide tolerance, specifically glufosinate ammonium, was also inserted into the organism.
 


 


Upload:
Date of authorization: 09/10/2016
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Competent National Authority: Ministry of Health and Medical Education- Food & Drug Administration. Risk Assessment file is uploaded. https://bch.cbd.int/en/database/RA/BCH-RA-IR-114041/2
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
ABRII
Contact person name:
Gholamreza Salehi Jouzani
Website:
Physical full address:
Agricultural Biotechnology Research Institute of Iran (ABRII), Mahdasht Road, 31535-1897, Karaj, Iran
Phone number:
0098(26)32701132
Fax number:
0098(26)32701132
Country introduction:

Iran has ratified Cartagena Protocol on Biosafety in 2003. The National Biosafety Law has also been ratified in 2009. The regulations for the National Biosafety Law have been prepared and approved during last ten years. All these laws and regulations deal with Living GMOs (LMOs) and there is no Law for the regulation of the non-living GMOs. All these laws and regulations are accessible at: http://bch.cbd.int/database/results?searchid=622770. Codex principles for the risk analysis of foods derived from modern biotechnology and other guidelines such as the Codex guidelines for the conduct of food safety assessment of foods produced using recombinant-DNA plants and microorganisms are widely accepted and used.

The process for authorization of new LMO release includes comprehensive risk assessment and management analysis. Ministry of Agriculture (Jihade Keshavarzi) is responsible for approval of the release, import, export, transit and use of Agricultural Related LMOs. The requests should be forwarded to: a[email protected]; with a CC to National Focal Point: [email protected]. Cartagena Protocol on Biosafety National Focal Point is in charge of all liaison affairs related to the Cartagena Protocol on Biosafety and acts as the contact point for the communications received. The Ministry of Health and Medical Education is in charge with the approval of all LMOs related to food and medicine. Environmental Protection Organization is in charge with the environmental release of LMOs in the wild nature and/or related to the wild organisms. Detailed procedure for authorization of GM food and feed is under preparation.

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
Agricultural Jihad Ministry
 
Tehran, Tehran
Iran (Islamic Republic of)
Phone: +98-21-64583301
Fax: +98-21-88947075
Email: [email protected]
Url: http://www.maj.ir

 

Ministry of Health and Medical Education- Food & Drug Administration
Food and Drug Administration, Fakhrerazi St., Enghelab Ave.
Tehran
Iran (Islamic Republic of), 1314715311
Phone: 009821-61927130
Fax: 009821-66405570
Email: [email protected],[email protected]
Url: http://fda.behdasht.gov.ir/

 

Iran
Name of product applicant: Dow AgroSciences & Pioneer Hi-Bred International Inc.
Summary of application:

Corn modified with the insertion of the Cry1F gene from Bacillus thuringiensis to confer resistance to the European corn borer (Ostrinia nubilalis). A transformation cassette coding for phosphinothricin (PPT) herbicide tolerance, specifically glufosinate ammonium, was also inserted into the organism.
 


 


Upload:
Date of authorization: 29/10/2016
Scope of authorization: Feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Competent National Authority: Ministry of Agriculture-Jehad, Agricultural Research, Education and Extension Organization (AREEO). Risk Assessment file is uploaded. https://bch.cbd.int/en/database/RA/BCH-RA-IR-114184/2
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
ABRII
Contact person name:
Gholamreza Salehi Jouzani
Website:
Physical full address:
Agricultural Biotechnology Research Institute of Iran (ABRII), Mahdasht Road, 31535-1897, Karaj, Iran
Phone number:
0098(26)32701132
Fax number:
0098(26)32701132
Country introduction:

Iran has ratified Cartagena Protocol on Biosafety in 2003. The National Biosafety Law has also been ratified in 2009. The regulations for the National Biosafety Law have been prepared and approved during last ten years. All these laws and regulations deal with Living GMOs (LMOs) and there is no Law for the regulation of the non-living GMOs. All these laws and regulations are accessible at: http://bch.cbd.int/database/results?searchid=622770. Codex principles for the risk analysis of foods derived from modern biotechnology and other guidelines such as the Codex guidelines for the conduct of food safety assessment of foods produced using recombinant-DNA plants and microorganisms are widely accepted and used.

The process for authorization of new LMO release includes comprehensive risk assessment and management analysis. Ministry of Agriculture (Jihade Keshavarzi) is responsible for approval of the release, import, export, transit and use of Agricultural Related LMOs. The requests should be forwarded to: a[email protected]; with a CC to National Focal Point: [email protected]. Cartagena Protocol on Biosafety National Focal Point is in charge of all liaison affairs related to the Cartagena Protocol on Biosafety and acts as the contact point for the communications received. The Ministry of Health and Medical Education is in charge with the approval of all LMOs related to food and medicine. Environmental Protection Organization is in charge with the environmental release of LMOs in the wild nature and/or related to the wild organisms. Detailed procedure for authorization of GM food and feed is under preparation.

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
Agricultural Jihad Ministry
 
Tehran, Tehran
Iran (Islamic Republic of)
Phone: +98-21-64583301
Fax: +98-21-88947075
Email: [email protected]
Url: http://www.maj.ir

 

Ministry of Health and Medical Education- Food & Drug Administration
Food and Drug Administration, Fakhrerazi St., Enghelab Ave.
Tehran
Iran (Islamic Republic of), 1314715311
Phone: 009821-61927130
Fax: 009821-66405570
Email: [email protected],[email protected]
Url: http://fda.behdasht.gov.ir/

 

Japan
Name of product applicant: Dow Chemical JapanLtd.
Summary of application:

Maize resistant to Lepidoptera and tolerant to glufosinate herbicide (cry1F, pat, Zea mays subsp. mays (L.) Iltis).

Upload:
Date of authorization: 08/07/2002
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): BioTrack Product Database
Summary of the safety assessment (food safety):
Please see the link below (in Japanese).
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: Food safety assessment performed by Ministry of Health, Labour and Welfare of Japan (in Japanese)
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Food Safety Commission Secretariat,Cabinet Office,
Contact person name:
Kojiro Yokonuma
Website:
Physical full address:
Akasaka 5-2-20 Minato Ward,Tokyo,Japan
Phone number:
81 3 6234 1122
Fax number:
81 3 3584 7392
Country introduction:
Safety assessments of GM foods are mandatory under the Food Sanitation Law in Japan. The Ministry of Health, Labour, and Welfare (MHLW) legally imposes safety assessments of GM foods so that those that have not undergone safety assessments would not be distributed in the country. MHLW receives application and requests the Food Safety COmmission of Japan (FSCJ) to evaluate the safety of GM foods in terms of human health. Safety assessments are carried out by FSCJ.
Useful links
Relevant documents
Stacked events:

With regard to stacked events, FSCJ conducts the safety assessment of GM food based on the “Policies Regarding the Safety Assessment of Stacked Varieties of Genetically Modified Plants”.

Even if single events that are stacked have already approved, some products will be considered as new products and some will not.

Please refer to Article 5 and 6 of the MHLW’s notice, which is available at the following URL, for the details.

http://www.mhlw.go.jp/file/06-Seisakujouhou-11130500-Shokuhinanzenbu/0000053519.pdf

Article 6 was modified in 2014, and the modified version is available at the following URL.

http://www.mhlw.go.jp/file/06-Seisakujouhou-11130500-Shokuhinanzenbu/0000049695.pdf

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Food Safety Commission of Japan (http://www.fsc.go.jp/english/index.html), Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/policy/health-medical/food/index.html)

Malaysia
Name of product applicant: Du Pont Production Agriscience (M) Sdn. Bhd.
Summary of application:

Please refer to uploaded document.

Upload:
Date of authorization: 08/01/2013
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): Department of Biosafety Malaysia
CBD Biosafety Clearing House
Summary of the safety assessment (food safety):
Please refer to uploaded document.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Department of Biosafety Malaysia
Contact person name:
Dr. Anita Anthonysamy
Website:
Physical full address:
Department of Biosafety, Ministry of Natural Resources, Environment and Climate Change Level 4, Block F11, Complex F Lebuh Perdana Timur, Precinct 1 62000 Putrajaya, Malaysia
Phone number:
+60380917322
Fax number:
+60380917371
Country introduction:

GM food safety assessment is a requirement by law under the Biosafety Act 2007 in Malaysia. The National Biosafety Board reviews and makes decisions on events based on a scientific/technical risk assessment, policy considerations as well as public input. The decisions and its related documents made are publicly available through the Malaysian Department of Biosafety Website and the Convention of Biological Diversity Biosafety Clearing House.

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Department of Biosafety, Ministry of Natural Resources, Environment and Climate Change Level 4, Block F11, Complex F Lebuh Perdana Timur, Precinct 1 62000 Putrajaya, Malaysia. Email: [email protected]. Url: www. biosafety.gov.my

Food Safety and Quality Division, Ministry of Health, Level 4, Menara Prisma, No. 26, Persiaran Perdana, Putrajaya, Malaysia, 62675. Phone: +603 88850797 Fax: +603 88850790 Email: [email protected]
Mexico
Name of product applicant: Híbridos Pioneer de México, S.A. de C.V. - Dow AgroSciences, S.A. de C.V.
Summary of application:

Authorization by COFEPRIS: 19


Maize resistant to Lepidoptera and tolerant to glufosinate herbicide (cry1F, pat, Zea mays subsp. mays (L.) Iltis).

Upload:
Date of authorization: 15/09/2003
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
UI OECD: DAS-Ø15Ø7-1 During the risk assessment of this GMO based on existing knowledge to date, no toxic or allergic effects neither substantial nutritional changes are observed. The event is as safe as its conventional counterpart. For more detail please find attached the risk assessment summary in this page.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
CIBIOGEM
Contact person name:
Dra. Consuelo López López
Website:
Physical full address:
San Borja #938, Col. Del Valle • Del. Benito Juárez C.P. 03100, México, D.F.
Phone number:
+52 (55) 53227700
Fax number:
Country introduction:

México ha buscado garantizar la inocuidad de los productos biotecnológicos para el uso y consumo de su población.

Desde 1984 el artículo 282 bis 1 de la Ley General de Salud, contempló que la Secretaría de Salud debería regular aquellos productos biotecnológicos, o sus derivados, destinados al uso o consumo humano.

En un inicio, con fundamento en este artículo, la Secretaria de Salud evaluó la inocuidad alimentaria de productos biotecnológicos, para su comercialización con fines de uso o consumo humano. A partir de 2005, con la entrada en vigor de la Ley de Bioseguridad de Organismos Genéticamente Modificados (LBOGM), se realizó la adecuación de la regulación para dar lugar a la Autorización que es el acto administrativo mediante el cual la Secretaría de Salud, a través de la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), autoriza Organismos Genéticamente Modificados (OGMs), a efecto de que se pueda realizar su comercialización, así como su utilización con finalidades de Salud Pública o de Biorremediación.

Las facultades que corresponden a la Secretaría de Salud se estipulan en el artículo 16 de la LBOGM y lo relativo a la Autorizaciones se describe en los artículos 91 al 98 de dicha Ley.

Quienes pretendan obtener una Autorización para Comercialización e Importación de OGMs deben presentar ante COFEPRIS, una solicitud por escrito acompañada de la información a que se refiere los artículos 23 al 32 del Reglamento de la Ley de Bioseguridad de OGMs.

http://www.conacyt.gob.mx/cibiogem/images/cibiogem/normatividad/vigente/LBOGM.pdf

http://www.conacyt.gob.mx/cibiogem/images/cibiogem/normatividad/vigente/Reg_LBOGM.pdf

 

Courtesy translation

Mexico has sought to guarantee the safety of biotechnological products the use and consumption of its population. Since 1984, article 282 bis 1 from the General Law of Health, considered that the Secretary of Health should regulate those biotechnological products, or their derivatives, intended for food and feed use. Initially, the Secretary of Health evaluated the food safety of biotechnological products, based on this article, for commercialization with purposes of food, feed and processing. Subsequently in 2005, with the entry into force of the Law on Biosafety of Genetically Modified Organisms (LBOGM), the regulation was adapted to give rise to the Authorization, which is the administrative act through which the Secretary of Health, by means of the Federal Commission for the Protection Against Sanitary Risks (COFEPRIS), authorizes Genetically Modified Organisms (GMOs), to their commercialization, as well as their use for purposes of public health or bioremediation.

The faculties that correspond to the Secretary of Health are stipulated in Article 16 of the LBOGM and what is related to the Authorizations is described in Articles 91 to 98 of this Law. Those who seek to obtain an Authorization for GMOs merchandising and importation, must present to COFEPRIS, a written request accompanied by the information referred into articles 23 to 32 of the Regulation of the Law on Biosafety of Genetically Modified Organisms.

http://www.conacyt.gob.mx/cibiogem/images/cibiogem/normatividad/vigente/LBOGM.pdf

http://www.conacyt.gob.mx/cibiogem/images/cibiogem/normatividad/vigente/Reg_LBOGM.pdf

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Secretaría de Salud / Teléfono: +52 55 5080 5200 / Correo electrónico: [email protected]%20

New Zealand
Name of product applicant: Dow AgroSciences Australia Pty Ltd
Summary of application:

The new genetic traits in the corn resulted from the introduction of two new genes encoding the bacterial proteins Cry 1F, conferring resistance to certain insect pests, and phosphinothricin acetyltransferase (PAT), an enzyme conferring tolerance to the synthetic herbicide, glufosinate-ammonium.

Bacillus thuringiensis, a common soil bacterium, produces a number of Cry proteins, known also as Bt proteins, with very selective insecticidal activity. One of the family of Cry proteins, known as Cry1F, has been shown in field research to be effective in controlling certain lepidopteran insect larvae such as those from the European Corn Borer (Ostrinia nubilalis), Southwestern corn borer (Diatraea grandiosella), black cutworm (Agrotis ipsilon) and armyworms (Spodoptera sp.). These insects are common pests of corn in the United States where it is intended for this variety to be grown commercially. The Cry1F protein is encoded by the cry1F gene derived from Bacillus thuringiensis subsp. aizawai.

The applicant claims that the presence of this genetic modification also results in a reduction in moulds and associated mycotoxins in the corn, in addition to the significant control of insect pests.

The PAT enzyme metabolises the herbicide glufosinate-ammonium (or L-phosphinothricin) into an inactive form. The enzyme is encoded by the pat gene which is derived from Streptomyces viridochromogenes, a common soil bacterium.

Corn is used predominantly as an ingredient in the manufacture of breakfast cereals, baking products, extruded confectionery and corn chips. Maize starch is used extensively by the food industry for the manufacture of many processed foods including dessert mixes and canned foods.

Despite the diverse uses of corn products in many foods, corn is a relatively minor crop in both Australia and New Zealand, with a declining area planted over the last decade. When required, products such as high-fructose corn syrup and maize starch are imported from major corn growing regions in the Northern Hemisphere, to meet manufacturing demand.

The cry1F gene is registered for full commercial use in the United States in field corn
originating from maize line 1507. Corn line 1507 has food, feed and environmental approval in Japan (2002) and food, feed and cultivation approval in Canada (2002). It is also undergoing assessment in Korea and is awaiting assessment in the European Union. Foods derived from corn line 1507 may enter the Australian and New Zealand markets in the future via imported products.

Upload:
Date of authorization: 13/11/2003
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): OECD BioTrack Product Database
Summary of the safety assessment (food safety):
FSANZ has completed a comprehensive safety assessment of corn line 1507 as required under the standard. Corn line 1507 contains two new genes, cry1F and pat, each derived from soil bacteria. The cry1F gene encodes an insecticidal protein that, like other Bt proteins, is highly selective in controlling Lepidopteran insects. The pat gene encodes an enzyme that inactivates the herbicide, allowing the plant to grow in the presence of the herbicide. The herbicide tolerance trait was also used to identify appropriate plants during development and therefore antibiotic resistance marker genes were not required in this case. Food derived from corn line 1507 has been evaluated according to the safety assessment guidelines prepared by FSANZ. The assessment considered the following aspects of the food: (1) the nature of the genetic modification; (2) general safety issues such as history of use and the potential for transfer of antibiotic resistance genes to microorganisms in the human digestive tract; (3) characterisation of novel proteins including toxicological and allergenicity issues; and (4) comparative compositional analyses and nutritional impact of the food. On the basis of an assessment of the available information, it is concluded that corn line 1507 is as safe and wholesome as food produced from other commercial corn varieties
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: Application A446 - Insect/Glufosinate Resistant Corn line1507
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Ministry for Primary Industries
Contact person name:
john vandenbeuken
Website:
Physical full address:
Pastoral House, 25 The Terrace, Wellington, 6012
Phone number:
0298942581
Fax number:
Country introduction:

New Zealand and Australia share a joint food regulation system for the composition of labelling of most foods. Food Standards Australia New Zealand (FSANZ) is the regulatory agency responsible for the development of the joint food standards in Australia and New Zealand. The main office (approximately 120 staff) is located in Canberra (in the Australian Capital Territory) and the smaller New Zealand office (approximately 15 staff) is located in Wellington on the North Island.

Useful links
Relevant documents
Stacked events:

FSANZ does not: Separately assess food from stacked event lines where food from the GM parents has already been approved; Mandate notification of stacked events by developers; Notify the public of stacked event ‘approvals’; List food derived from stacked event lines in the Code, unless the stacked event line has been separately assessed as a single line e.g. Application A518: MXB-13 cotton (DAS-21023-5 x DAS-24236-5)

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Food Standards Australia New Zealand (FSANZ) (http://www.foodstandards.gov.au)

Paraguay
Name of product applicant: DOW AGROTEC
Summary of application:

Corn modified with the insertion of the Cry1F gene from Bacillus thuringiensis to confer resistance to the European corn borer (Ostrinia nubilalis). A transformation cassette coding for phosphinothricin (PPT) herbicide tolerance, specifically glufosinate ammonium, was also inserted into the organism.

Upload:
Date of authorization: 24/10/2012
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): DAS-Ø15Ø7-1
Summary of the safety assessment (food safety):
The Commercial Release Opinion of the National Commission for Agricultural and Forestry Biosafety (CONBIO), in its substantial part states: "...Recommends technically: (1) The commercial release of the event 1507 (2) In case of detection of an unexpected effect, the company is obliged to inform CONBIO".
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Ministerio de Agricultura y Ganadería
Contact person name:
Santiago Bertoni
Website:
Physical full address:
Yegros 437 entre 25 de mayo y Cerro Cora
Phone number:
+595 981 256262
Fax number:
Country introduction:

The agricultural sector is one of the economic pillars of Paraguay in its contribution to the GDP, with the main crops being soybean, cassava, maize, wheat, sugar cane, and cotton. It should also be noted that Paraguay is the world’s fourth exporter of soybean. In 2020, the area planted with crops was 4.67 million hectares and consisted of soybean (3.56 million hectares), maize (1.08 million hectares), and cotton (18,000 hectares). Agricultural biotechnology was first regulated in Paraguay in 1997. In 2012, the system was adjusted through the creation of the National Agricultural and Forestry Biosafety Commission (CONBIO), “with the mission to manage, analyze, and issue recommendations on all matters related to the introduction, confined field trials, pre-commercial and commercial release, and other intended uses of GE crops” Almost 94% of the soybean, 36% of the maize, and 56% of the cotton planted in the country are GE.

Useful links
Relevant documents
Stacked events:

When a stacked event is approved, all possible combinations are approved. Previously evaluated single events are not reevaluated in stacks.

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

In 2012, the system was adjusted through the creation of the National Agricultural and Forestry Biosafety Commission (CONBIO), “with the mission to manage, analyze, and issue recommendations on all matters related to the introduction, confined field trials, pre-commercial and commercial release, and other intended uses of GE crops”. Additional information https://conbio.mag.gov.py/

Philippines
Name of product applicant: Pioneer Hi Bred and Dow AgroSciences
Summary of application:
Pioneer Hi-Bred International, Inc. (PHI) and Dow Agro Sciences (DAS) have developed a corn line resistant to the Asiatic Corn Borer (ACB) larvae, a periodic pest of corn in the Philippines. This corn line, referred to in this document as Cry1F, was developed to provide a method to control yield losses from insect feeding damage caused by the larval stages of ACB, without the use of conventional pesticides. In addition, Cry1F was transformed with a gene that confers tolerance to the herbicide glufosinate.
Upload:
Date of authorization: 07/10/2013
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Pioneer Hi-Bred and Dow AgroSciences submitted an application to the Bureau of Plant Industry (BPI) requesting for biosafety permit under Administrative Order #8 for Cry1F insect-resistant, glufosinate tolerant maize line containing transformation event 1507. Extensive safety evaluation of B.t. Cry 1F maize line 1507 in terms of genetic stability, agronomic characteristics, food compositional analysis, and potential toxicity and allergenicity was undertaken by the concerned agencies of the Department of Agriculture (DA): [Bureau of Animal Industry (BAI), and Bureau of Agriculture, Fisheries and Product Standards (BAFPS)] and a Scientific Technical Review Panel (STRP) following the DA AO8 guidelines for the release of genetically modified organisms. The Public Information Sheet (PIS) of the said application was published in two widely circulated newspapers for public comments/review. BPI received no comment on the petition during the 30-day comment period. Review of results of evaluation by the BPI Biotech Core Team in consultation with DA-Biotechnology Advisory Team (DA-BAT) completed the approval process.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Bureau of Plant Industry
Contact person name:
Geronima P. Eusebio
Website:
Physical full address:
San Andres St., Malate, Manila
Phone number:
632 404 0409 loc 203
Fax number:
Country introduction:

In 1987, scientists from the University of the Philippines Los Banos (UPLB) and the International Rice Research Institute (IRRI), the Quarantine Officer of the Bureau of Plant Industry (BPI), and the Director for Crops of the Philippine Council for Agriculture, Forestry and Natural Resources Research and Development (PCARRD), recognizing the potential harm of the introduction of exotic species and genetic engineering, formed a committee and formulated the biosafety protocols and guidelines for genetic engineering and related research activities for UPLB and IRRI researchers. The committee went on to draft a Philippine biosafety policy, which was submitted to the Office of the President. On October 15, 1990, recognizing the potential for modern biotechnology both in improving the lives of the people and in creating hazards if not handled properly, President Corazon C. Aquino issued Executive Order 430 creating the National Committee on Biosafety of the Philippines (NCBP) that will formulate, review and amend national policy on biosafety and formulate guidelines on the conduct of activities on genetic engineering. The NCBP is comprised of representative of the Departments of Agriculture (DA); Environment and Natural Resources (DENR); Health (DOH); and Science and Technology (DOST), 4 scientists in biology, environmental science, social science and physical science; and 2 respected members of the community. On July 16, 2001, President Gloria Macapagal-Arroyo issued the Policy Statement on Modern Biotechnology, reiterating the government policy on promoting the safe and responsible use of modern biotechnology. On April 3, 2002, Department of Agriculture Administrative Order No. 8, Series of 2002 was issued implementing the guidelines for importation and release into the environment of Plants and Plant Products Derived from the Use of Modern Biotechnology. On March 17, 2006, President Gloria Macapagal-Arroyo issued Executive Order No.514 Establishing the National Biosafety Framework, prescribing guidelines for its implementation, reorganizing the National Committee on Biosafety of the Philippines, and for other purposes. On December 8, 2015, the Philippine Supreme Court declared DA AO8 null and void and any application for contained use, field testing, propagation and commercialization, and importation of GMOs was temporarily enjoined. In response to the nullification of DA AO8, the Technical Working Group composed of representatives from the Departments of Agriculture (DA), Science and Technology (DOST), Environment and Natural Resources (DENR), Health (DOH), and Interior and Local Government (DILG) drafted the Joint Department Circular No. 1, Series of 2016 (JDC No.1, S2016) titled 'Rules and Regulations for the Research and Development, Handling and Use, Transboundary Movement, Release into the Environment, and Management of Genetically-Modified Plant and Plant Products Derived from the Use of Modern Biotechnology'. There were series of meeting and five public consultations conducted before the JDC No.1, S2016 was approved and signed by the Secretaries of the abovementioned agencies on March 7, 2016 and took effect on April 15, 2016. Under this Circular, more government agencies were involved such as the Department of Science and Technology (DOST) to regulate applications for contained use and confined test of regulated articles; Department of Agriculture (DA) to evaluate applications for field trial, commercial propagation and transboundary movement of regulated articles; Department of Environment and Natural Resources (DENR) to evaluate environmental risks and impacts of regulated articles; Department of Health (DOH) to evaluate of environmental health impacts of regulated articles; and Department of the Interior and Local Government (DILG) to supervise public consultation during field trial.

 

Useful links
Relevant documents
Stacked events:

Gene stacking in plants can be conferred either through genetic engineering or conventional breeding A full risk assessment as to food and feed or for processing shall be conducted to plant products carrying stacked genes conferred through genetic engineering or conventional breeding, where the individual traits have no prior approval for direct use as food and feed or processing from the Bureau of Plant Industry (BPI) A desktop or documentary risk assessment on the possible or expected interactions between the genes shall be conducted for stacked gene products with multiple traits conferred through conventional breeding and individual events granted prior approval by the Bureau of Plant Industry.

 

Plant Products Carrying Stacked Genes Conferred Through (a) Genetic Engineering or b) Conventional Breeding, with Individual Traits That Have No Prior Approval:

A full risk assessnent as to  food and feed or processing shall be conducted,consistent with Part V of AO No. 8,"Approval Process For the Importation of Regulated Articles for Direct Use as Food and Feed or For Processing for plant products with multiple traits conferred through:

(a) genetic engineering, or

(b) conventional breeding, where the individual traits have no prior approval from the Bureau of Plant Industry (BPI) for direct use as food and feed or processing.

Plant Products Carrying Stacked Genes Conferred through Conventional Breeding:

For plant products with multiple traits conferred through conventional breeding,with all individual events granted prior approval and included in the Approval Registry, a notlfication shall be submitted by the technology developer to the BPI, which shall conduct an evaluation in accordance with the relevant criteria in Annex I of this Memorandum Circular. The list of data contained in Annex I will not preclude the inclusion of other issues and concerns that will be raised by the BPI and the Scientific and Technical Review Panel (STRP) during the course of the desktop review.

Notificatlon Requirement for Plant Products Carrying Stacked Genes

All technology developers shall submit a notification to the Bureau of Plant Industry of their developed plant products carrying stacked genes and shall be required to comply with the relevant approval process listed above.

The Bureau of Plant Industry shall issue a certiflcate as to the approval of the stacked gene product and shall likewise include the transformation event in the official approval registry of plant products for food and feed or processing.

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Bureau of Plant Industry 692 San Andres St, Malate, Manila 1004

Philippines
Name of product applicant: Pioneer Hi-Bred Philippines, Inc. and DOW Agrosciences
Summary of application:

On May 8, 2018, Pioneer Hi-Bred Philippines and Dow Agrosciences Philippines submitted corn TC1507 application for direct use as food and feed, or for processing to the Bureau of Plant Industry (BPI) under the DOST-DA-DENR-DOH-DILG Joint Department Circular (JDC) No. 1 Series of 2016. After reviewing the Risk Assessment Report and attachments submitted by the applicant, the assessors namely: Scientific and Technical Review Panel (STRP), BPI- Plant Products Safety Services Division (BPI-PPSSD) and Bureau of Animal Industry (BAI), concurred that corn TC1507 is as safe for human food and animal feed as its conventional counterpart.

Upload:
Date of authorization: 21/06/2021
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Toxicological Assessment Digestibility study provided by the developer indicated that Cry1F and PAT is rapidly degraded in simulated gastric fluid (SGF〕. Hence, the estimated T50 result for SGF is 15 seconds. The susceptibility of Cry1F protein to proteolytic degradation was evaluated in the simulated mammalian gastric fluid (SGF) containing pepsin using SDS-PAGE and Western Blot Analysis. The degradation of PAT appeared to be complete by 5 sec. The susceptibility of PAT protein to proteolytic degradation was evaluated in the simulated mammalian gastric fluid (SGF) containing pepsin using SDS-PAGE. The loss of PAT activity was instantaneous and irreversible at 37°C in SGF with or without pepsin. Cry1F protein was heat inactivated after exposure to 75 °C or 90°C for 30 min while PAT protein was completely heat inactivated after 10 minutes at 50 °C or higher temperatures despite the fact that the protein was not degraded. Bioinformatics analyses using BLASTP sequence alignment program and DuPont Pioneer toxin database provided by the developer indicated that Cry1F and PAT have no significant homology to any known toxin. Furthermore, acute oral toxicity study provided by the developer indicated no treatment related adverse effects on survival, clinical observations, body weight gain, food consumption or gross pathology of mice administered with Cry1F and PAT protein. Allergenicity Assessment The results of the SDS-PAGE and western blot assay demonstrate that Cry1F protein is rapidly degraded and undetectable in simulated gastric fluid containing pepsin after 15 seconds while PAT protein was degraded in 5 seconds. The inactivation of CrylF protein provided by the developer indicated that the loss of biological activity was observed upon incubation at 75°C. The activity is significantly impacted by heat treatment. The PAT protein was completely heat inactivated after 10 minutes at 50°C or higher temperatures despite the fact that the protein was not degraded. J. Nutritional Data The assessors reported that the proximates and fiber in grain and forage from TC1507 maize were compared to proximates and fiber from grain and forage from non-transgenic maize with similar genetic background (Stauffer and Zeph, 2000). A difference in the percentage of fat between the transgenic line and its comparator was statistically significant (p<0.05) in grain, but values were within the reported range in literature for this variable, therefore the differences are not biologically relevant. Compositional assessment of vitamins, minerals, fatty acid and amino acid content of grain from TC1507 maize and near-isoline control maize was conducted. For Vitamins, satistically significant differences between TC1507 maize and the control line were noted in total tocopherols and in vitamin B1 levels but the values were within range of values reported in the literature. For Minerals, statistically significant differences between TC1507 maize and the control line were noted in manganese and potassium levels but the values were within range of values reported in the literature or within the data set obtained from the commercial lines for these variables. For fatty acids, statistically significant differences were observed between TC1507 maize and the control line in all measurements except for the levels of palmitic acid. However, the values for these fatty acids in both maize lines were within the range reported in literature for maize. For amino acids, statistically significant differences between the two lines in two values, cysteine and methionine were observed but values fall within the reported range in literature or within the data set obtained from the commercial lines for these variables In summary, the statistically significant variations between TC1507 maize and the control line that were observed in the compositional assessment were not biologically relevant. On the other hand, phytic acid, trypsin inhibitor and raffinose were analyzed in grain from maize TC1507 maize and the non-GM control line. Phytic acid and raffinose levels in TC1507 maize were not significantly different from the non-GM control maize line. As expected, trypsin inhibitor levels in both TC1507 maize and the control line were below the limit of quantitation of the enzyme assay that was used in this analysis. It was noted that the processing of grain is not expected to create significant variations between TC1507 maize and conventional maize in antinutrient composition. The assessors find scientific evidence that the regulated article applied for human food and animal feed use is as safe as its conventional counterpart and shall not pose any significant risk to human and animal health
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date) February 20, 2024
E-mail:
Organization/agency name (Full name):
Bureau of Plant Industry
Contact person name:
Geronima P. Eusebio
Website:
Physical full address:
San Andres St., Malate, Manila
Phone number:
632 404 0409 loc 203
Fax number:
Country introduction:

In 1987, scientists from the University of the Philippines Los Banos (UPLB) and the International Rice Research Institute (IRRI), the Quarantine Officer of the Bureau of Plant Industry (BPI), and the Director for Crops of the Philippine Council for Agriculture, Forestry and Natural Resources Research and Development (PCARRD), recognizing the potential harm of the introduction of exotic species and genetic engineering, formed a committee and formulated the biosafety protocols and guidelines for genetic engineering and related research activities for UPLB and IRRI researchers. The committee went on to draft a Philippine biosafety policy, which was submitted to the Office of the President. On October 15, 1990, recognizing the potential for modern biotechnology both in improving the lives of the people and in creating hazards if not handled properly, President Corazon C. Aquino issued Executive Order 430 creating the National Committee on Biosafety of the Philippines (NCBP) that will formulate, review and amend national policy on biosafety and formulate guidelines on the conduct of activities on genetic engineering. The NCBP is comprised of representative of the Departments of Agriculture (DA); Environment and Natural Resources (DENR); Health (DOH); and Science and Technology (DOST), 4 scientists in biology, environmental science, social science and physical science; and 2 respected members of the community. On July 16, 2001, President Gloria Macapagal-Arroyo issued the Policy Statement on Modern Biotechnology, reiterating the government policy on promoting the safe and responsible use of modern biotechnology. On April 3, 2002, Department of Agriculture Administrative Order No. 8, Series of 2002 was issued implementing the guidelines for importation and release into the environment of Plants and Plant Products Derived from the Use of Modern Biotechnology. On March 17, 2006, President Gloria Macapagal-Arroyo issued Executive Order No.514 Establishing the National Biosafety Framework, prescribing guidelines for its implementation, reorganizing the National Committee on Biosafety of the Philippines, and for other purposes. On December 8, 2015, the Philippine Supreme Court declared DA AO8 null and void and any application for contained use, field testing, propagation and commercialization, and importation of GMOs was temporarily enjoined. In response to the nullification of DA AO8, the Technical Working Group composed of representatives from the Departments of Agriculture (DA), Science and Technology (DOST), Environment and Natural Resources (DENR), Health (DOH), and Interior and Local Government (DILG) drafted the Joint Department Circular No. 1, Series of 2016 (JDC No.1, S2016) titled 'Rules and Regulations for the Research and Development, Handling and Use, Transboundary Movement, Release into the Environment, and Management of Genetically-Modified Plant and Plant Products Derived from the Use of Modern Biotechnology'. There were series of meeting and five public consultations conducted before the JDC No.1, S2016 was approved and signed by the Secretaries of the abovementioned agencies on March 7, 2016 and took effect on April 15, 2016. Under this Circular, more government agencies were involved such as the Department of Science and Technology (DOST) to regulate applications for contained use and confined test of regulated articles; Department of Agriculture (DA) to evaluate applications for field trial, commercial propagation and transboundary movement of regulated articles; Department of Environment and Natural Resources (DENR) to evaluate environmental risks and impacts of regulated articles; Department of Health (DOH) to evaluate of environmental health impacts of regulated articles; and Department of the Interior and Local Government (DILG) to supervise public consultation during field trial.

 

Useful links
Relevant documents
Stacked events:

Gene stacking in plants can be conferred either through genetic engineering or conventional breeding A full risk assessment as to food and feed or for processing shall be conducted to plant products carrying stacked genes conferred through genetic engineering or conventional breeding, where the individual traits have no prior approval for direct use as food and feed or processing from the Bureau of Plant Industry (BPI) A desktop or documentary risk assessment on the possible or expected interactions between the genes shall be conducted for stacked gene products with multiple traits conferred through conventional breeding and individual events granted prior approval by the Bureau of Plant Industry.

 

Plant Products Carrying Stacked Genes Conferred Through (a) Genetic Engineering or b) Conventional Breeding, with Individual Traits That Have No Prior Approval:

A full risk assessnent as to  food and feed or processing shall be conducted,consistent with Part V of AO No. 8,"Approval Process For the Importation of Regulated Articles for Direct Use as Food and Feed or For Processing for plant products with multiple traits conferred through:

(a) genetic engineering, or

(b) conventional breeding, where the individual traits have no prior approval from the Bureau of Plant Industry (BPI) for direct use as food and feed or processing.

Plant Products Carrying Stacked Genes Conferred through Conventional Breeding:

For plant products with multiple traits conferred through conventional breeding,with all individual events granted prior approval and included in the Approval Registry, a notlfication shall be submitted by the technology developer to the BPI, which shall conduct an evaluation in accordance with the relevant criteria in Annex I of this Memorandum Circular. The list of data contained in Annex I will not preclude the inclusion of other issues and concerns that will be raised by the BPI and the Scientific and Technical Review Panel (STRP) during the course of the desktop review.

Notificatlon Requirement for Plant Products Carrying Stacked Genes

All technology developers shall submit a notification to the Bureau of Plant Industry of their developed plant products carrying stacked genes and shall be required to comply with the relevant approval process listed above.

The Bureau of Plant Industry shall issue a certiflcate as to the approval of the stacked gene product and shall likewise include the transformation event in the official approval registry of plant products for food and feed or processing.

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Bureau of Plant Industry 692 San Andres St, Malate, Manila 1004

Philippines
Name of product applicant: Pioneer Hi-Bred Philippines, Inc.
Summary of application:

On May 8, 2018, Pioneer Hi-Bred Philippines and Dow Agrosciences Philippines submitted corn TC1507 application for direct use as food and feed, or for processing to the Bureau of Plant Industry (BPI) under the DOST-DA-DENR-DOH-DILG Joint Department Circular (JDC) No. 1 Series of 2016. After reviewing the Risk Assessment Report and attachments submitted by the applicant, the assessors namely: Scientific and Technical Review Panel (STRP), BPI- Plant Products Safety Services Division (BPI-PPSSD) and Bureau of Animal Industry (BAI), concurred that corn TC1507 is as safe for human food and animal feed as its conventional counterpart.

Upload:
Date of authorization: 21/02/2019
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Toxicological Assessment Digestibility study provided by the developer indicated that Cry1F and PAT is rapidly degraded in simulated gastric fluid (SGF〕. Hence, the estimated T50 result for SGF is 15 seconds. The susceptibility of Cry1F protein to proteolytic degradation was evaluated in the simulated mammalian gastric fluid (SGF) containing pepsin using SDS-PAGE and Western Blot Analysis. The degradation of PAT appeared to be complete by 5 sec. The susceptibility of PAT protein to proteolytic degradation was evaluated in the simulated mammalian gastric fluid (SGF) containing pepsin using SDS-PAGE. The loss of PAT activity was instantaneous and irreversible at 37°C in SGF with or without pepsin. Cry1F protein was heat inactivated after exposure to 75 °C or 90°C for 30 min while PAT protein was completely heat inactivated after 10 minutes at 50 °C or higher temperatures despite the fact that the protein was not degraded. Bioinformatics analyses using BLASTP sequence alignment program and DuPont Pioneer toxin database provided by the developer indicated that Cry1F and PAT have no significant homology to any known toxin. Furthermore, acute oral toxicity study provided by the developer indicated no treatment related adverse effects on survival, clinical observations, body weight gain, food consumption or gross pathology of mice administered with Cry1F and PAT protein. Allergenicity Assessment The results of the SDS-PAGE and western blot assay demonstrate that Cry1F protein is rapidly degraded and undetectable in simulated gastric fluid containing pepsin after 15 seconds while PAT protein was degraded in 5 seconds. The inactivation of CrylF protein provided by the developer indicated that the loss of biological activity was observed upon incubation at 75°C. The activity is significantly impacted by heat treatment. The PAT protein was completely heat inactivated after 10 minutes at 50°C or higher temperatures despite the fact that the protein was not degraded. Nutritional Data The assessors reported that the proximates and fiber in grain and forage from TC1507 maize were compared to proximates and fiber from grain and forage from non-transgenic maize with similar genetic background (Stauffer and Zeph, 2000). A difference in the percentage of fat between the transgenic line and its comparator was statistically significant (p<0.05) in grain, but values were within the reported range in literature for this variable, therefore the differences are not biologically relevant. Compositional assessment of vitamins, minerals, fatty acid and amino acid content of grain from TC1507 maize and near-isoline control maize was conducted. For Vitamins, satistically significant differences between TC1507 maize and the control line were noted in total tocopherols and in vitamin B1 levels but the values were within range of values reported in the literature. For Minerals, statistically significant differences between TC1507 maize and the control line were noted in manganese and potassium levels but the values were within range of values reported in the literature or within the data set obtained from the commercial lines for these variables. For fatty acids, statistically significant differences were observed between TC1507 maize and the control line in all measurements except for the levels of palmitic acid. However, the values for these fatty acids in both maize lines were within the range reported in literature for maize. For amino acids, statistically significant differences between the two lines in two values, cysteine and methionine were observed but values fall within the reported range in literature or within the data set obtained from the commercial lines for these variables In summary, the statistically significant variations between TC1507 maize and the control line that were observed in the compositional assessment were not biologically relevant. On the other hand, phytic acid, trypsin inhibitor and raffinose were analyzed in grain from maize TC1507 maize and the non-GM control line. Phytic acid and raffinose levels in TC1507 maize were not significantly different from the non-GM control maize line. As expected, trypsin inhibitor levels in both TC1507 maize and the control line were below the limit of quantitation of the enzyme assay that was used in this analysis. It was noted that the processing of grain is not expected to create significant variations between TC1507 maize and conventional maize in antinutrient composition. The assessors find scientific evidence that the regulated article applied for human food and animal feed use is as safe as its conventional counterpart and shall not pose any significant risk to human and animal health
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date) February 20, 2024
E-mail:
Organization/agency name (Full name):
Bureau of Plant Industry
Contact person name:
Geronima P. Eusebio
Website:
Physical full address:
San Andres St., Malate, Manila
Phone number:
632 404 0409 loc 203
Fax number:
Country introduction:

In 1987, scientists from the University of the Philippines Los Banos (UPLB) and the International Rice Research Institute (IRRI), the Quarantine Officer of the Bureau of Plant Industry (BPI), and the Director for Crops of the Philippine Council for Agriculture, Forestry and Natural Resources Research and Development (PCARRD), recognizing the potential harm of the introduction of exotic species and genetic engineering, formed a committee and formulated the biosafety protocols and guidelines for genetic engineering and related research activities for UPLB and IRRI researchers. The committee went on to draft a Philippine biosafety policy, which was submitted to the Office of the President. On October 15, 1990, recognizing the potential for modern biotechnology both in improving the lives of the people and in creating hazards if not handled properly, President Corazon C. Aquino issued Executive Order 430 creating the National Committee on Biosafety of the Philippines (NCBP) that will formulate, review and amend national policy on biosafety and formulate guidelines on the conduct of activities on genetic engineering. The NCBP is comprised of representative of the Departments of Agriculture (DA); Environment and Natural Resources (DENR); Health (DOH); and Science and Technology (DOST), 4 scientists in biology, environmental science, social science and physical science; and 2 respected members of the community. On July 16, 2001, President Gloria Macapagal-Arroyo issued the Policy Statement on Modern Biotechnology, reiterating the government policy on promoting the safe and responsible use of modern biotechnology. On April 3, 2002, Department of Agriculture Administrative Order No. 8, Series of 2002 was issued implementing the guidelines for importation and release into the environment of Plants and Plant Products Derived from the Use of Modern Biotechnology. On March 17, 2006, President Gloria Macapagal-Arroyo issued Executive Order No.514 Establishing the National Biosafety Framework, prescribing guidelines for its implementation, reorganizing the National Committee on Biosafety of the Philippines, and for other purposes. On December 8, 2015, the Philippine Supreme Court declared DA AO8 null and void and any application for contained use, field testing, propagation and commercialization, and importation of GMOs was temporarily enjoined. In response to the nullification of DA AO8, the Technical Working Group composed of representatives from the Departments of Agriculture (DA), Science and Technology (DOST), Environment and Natural Resources (DENR), Health (DOH), and Interior and Local Government (DILG) drafted the Joint Department Circular No. 1, Series of 2016 (JDC No.1, S2016) titled 'Rules and Regulations for the Research and Development, Handling and Use, Transboundary Movement, Release into the Environment, and Management of Genetically-Modified Plant and Plant Products Derived from the Use of Modern Biotechnology'. There were series of meeting and five public consultations conducted before the JDC No.1, S2016 was approved and signed by the Secretaries of the abovementioned agencies on March 7, 2016 and took effect on April 15, 2016. Under this Circular, more government agencies were involved such as the Department of Science and Technology (DOST) to regulate applications for contained use and confined test of regulated articles; Department of Agriculture (DA) to evaluate applications for field trial, commercial propagation and transboundary movement of regulated articles; Department of Environment and Natural Resources (DENR) to evaluate environmental risks and impacts of regulated articles; Department of Health (DOH) to evaluate of environmental health impacts of regulated articles; and Department of the Interior and Local Government (DILG) to supervise public consultation during field trial.

 

Useful links
Relevant documents
Stacked events:

Gene stacking in plants can be conferred either through genetic engineering or conventional breeding A full risk assessment as to food and feed or for processing shall be conducted to plant products carrying stacked genes conferred through genetic engineering or conventional breeding, where the individual traits have no prior approval for direct use as food and feed or processing from the Bureau of Plant Industry (BPI) A desktop or documentary risk assessment on the possible or expected interactions between the genes shall be conducted for stacked gene products with multiple traits conferred through conventional breeding and individual events granted prior approval by the Bureau of Plant Industry.

 

Plant Products Carrying Stacked Genes Conferred Through (a) Genetic Engineering or b) Conventional Breeding, with Individual Traits That Have No Prior Approval:

A full risk assessnent as to  food and feed or processing shall be conducted,consistent with Part V of AO No. 8,"Approval Process For the Importation of Regulated Articles for Direct Use as Food and Feed or For Processing for plant products with multiple traits conferred through:

(a) genetic engineering, or

(b) conventional breeding, where the individual traits have no prior approval from the Bureau of Plant Industry (BPI) for direct use as food and feed or processing.

Plant Products Carrying Stacked Genes Conferred through Conventional Breeding:

For plant products with multiple traits conferred through conventional breeding,with all individual events granted prior approval and included in the Approval Registry, a notlfication shall be submitted by the technology developer to the BPI, which shall conduct an evaluation in accordance with the relevant criteria in Annex I of this Memorandum Circular. The list of data contained in Annex I will not preclude the inclusion of other issues and concerns that will be raised by the BPI and the Scientific and Technical Review Panel (STRP) during the course of the desktop review.

Notificatlon Requirement for Plant Products Carrying Stacked Genes

All technology developers shall submit a notification to the Bureau of Plant Industry of their developed plant products carrying stacked genes and shall be required to comply with the relevant approval process listed above.

The Bureau of Plant Industry shall issue a certiflcate as to the approval of the stacked gene product and shall likewise include the transformation event in the official approval registry of plant products for food and feed or processing.

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Bureau of Plant Industry 692 San Andres St, Malate, Manila 1004

Republic of Korea
Name of product applicant: DuPont (Korea) Inc.
Summary of application:

Glufosinate herbicide tolerance, Lepidopteran insect resistance

Upload:
Date of authorization: 05/11/2004
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Please see the link below(in Korean).
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Ministry of Food and Drug Safety
Contact person name:
Website:
Physical full address:
Osong Health Technology Administration Complex, 187, Osongsaengmyeong 2-ro, Osong-eup, Cheongwon-gun, Chungcheonbuk-do, 363-700, Korea
Phone number:
82-43-719-2360
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
Russian Federation
Name of product applicant: Pioneer Hi-Bred International, Inc and Dow AgroSciences LLC
Summary of application:

There were submitted (1) data enabling to identify the matter of research (species, variety, and the transformation event); (2) data on the initial parental organism and the donor organism for introduced genetic sequences;  (3) data on the genetic modification method, genetic construction, and the level of gene expression; (4) data on identification of GM maize line TC1507 (identification methods, protocol of analysis, description of primers, reference materials); (5) data on registration of the GM line  in other countries and the results of safety assessment which conducted for registration purposes of GMO in other countries.

Upload:
Date of authorization: 23/03/2017
Scope of authorization: Food
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Peer review of the data submitted by the applicant and the results of complex medical and biological studies of transgenic maize line TC1507 tolerant to lepidopteran pests and glufosinate herbicides, attest to the absence of any toxic, reprotoxic, genotoxic, or allergenic effects of this maize line. By biochemical composition, transgenic maize line TC1507 was identical to conventional maize. GM maize line TC1507 tolerant to lepidopteran pests and glufosinate herbicides has been registered for food use, listed in the State Register, and licensed for use in the territory of the Russian Federation, import into the territory of the Russian Federation, and placing on the market without restrictions.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
FSBI «Institute of Nutrition» RAMS
Contact person name:
Nadezhda Tyshko
Website:
Physical full address:
109240, Russia, Moscow, Ustinsky Proezd, 2/14
Phone number:
+7(495)698-53-64
Fax number:
Country introduction:

The development of the GMO safety assessment currently used in the Russian Federation started in 1995–1996. The methodological approaches to comprehensive complex medical and biological assessment of GMOs were developed in the Russian Federation with due regard for international and national experience as well as new scientific approaches based on the achievements of contemporary fundamental science: genomic and proteomic analysis, detection of DNA damage or mutagenic activity, identification of products of free-radical modifications of DNA or other sensitive biomarkers. GMO safety assessment is carried out for the state registration. Any novel food derived from plant GMO produced in Russia or imported into Russia for the first time is subject to the state registration . Guidance for safety assessment is specified in MU 2.3.2.2306-07 “Medico-Biological Safety Assessment of Plant Genetically Modified Organisms”. According to the accepted regulations,the human health assessment of a novel GMO to be placed on the domestic market includes the following: ■ Molecular assessment includes analysis of genetic construction, genetic modification method, and the gene expression level. ■ Technological assessment includes determination of organoleptic and functional properties, analysis of technological characteristics of the finished products. ■ Human health safety assessment includes several sections of required assessments: analysis of compositional equivalence and toxicological,genotoxicological, and allergological safety studies. ■ Methods for identification include qualitative and quantitative assay of GMO in food (studies targeted at determination of correspondence of these methods to those used in Russia in order to provide monitoring of use and labeling of GM food). The list and the scope of required studies is determined on the basis of analysis of information of the GMO submitted for registration; however, the above-mentioned studies are required. If significant changes in the GMO’s genome, proteome, or metabolome are shown, additional studies may be required to determine: biological value and absorbency reproductive effect; gonadotoxic, embryotoxic, teratotoxic effect; potential carcinogenic effect; lifetime, etc.

Useful links
Relevant documents
Stacked events:

Russia follows the national Methodical Guidelines  2.3.2.3388-16 “Medical and biological safety assessment of genetically modified stack events of plant origin ”

Our position regarding GM stacks registration is very close to the EU approach.

 

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Federal Research Centre of nutrition and biotechnology Viktor A. Tutelyan Ustinsky proezd, 2/14 109240 Moscow, RUSSIA E-mail: [email protected] Tel.:+7 495 698-53-60

Singapore
Name of product applicant: Dupont
Summary of application:

Apply for use as food, feed or for processing

Upload:
Date of authorization: 25/01/2011
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Corn line 1507 (DAS-01507-1) contains two new genes, cry1F (derived from the soil bacterium Bacillus thuringiensis var. aizawai strain PS811) and pat (derived from the soil bacterium Streptomyces viridochromogenes). The cry1F gene encodes an insecticidal protein, Cry1F, is highly selective in controlling Lepidopteran insects. The pat gene encodes PAT enzyme that confers tolerance to glufosinate-ammonium herbicides. Line 1507 contains one complete copy of the transformation cassette incorporating the two linked genes, cry1F and pat. Molecular analyses of corn line 1507 indicate that the transferred genes are stably integrated into the plant genome. The Cry1F and PAT proteins are non-toxic and non-allergenic to humans. Compositional analysis showed that food from modified corn line is similar to food from traditional corn lines. Food derived from corn line 1507 is as safe as foods derived from other corn varieties.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Singapore Food Agency (SFA)
Contact person name:
Dr Tan Yong Quan
Website:
Physical full address:
52 Jurong Gateway Road 14-01 JEM Office Tower Singapore 608550
Phone number:
(65)68052750
Fax number:
Country introduction:

The Singapore Food Agency (SFA) is a Statutory Board established under the Ministry of Sustainability and the Environment (MSE) to oversee food safety and security. SFA’s mission is to ensure and secure a supply of safe food.  SFA adopts a risk-based approach to food safety. Foods with foodborne hazards that may pose potential food safety risks to consumers are subjected to more stringent checks, regardless of their country of origin. SFA has in place an integrated system to ensure that both imported and domestically produced foods are safe for consumption.  The system comprises control measures such as source accreditation, inspection and surveillance of food, laboratory analysis, food legislation and recall of food products, which safeguard food safety from farm to fork.

Useful links
Relevant documents
Stacked events:

More information on the guidelines for the safety assessment of stacked events can be found on GMAC’s website:

http://www.gmac.sg/Index_Singapore_Guidelines_on_the_Release_of_Agriculture_Related_GMOs.html

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Singapore Food Agency (SFA)

Türkiye
Name of product applicant: Special case: please show below
Summary of application:

Application for direct use as feed


 Turkish Biosafety Law, entered in force in 2010, diverges from EU legislations in some points such as food and feed use require different separate applications, risk assessments and approvals.  Addition, our Law forsees prision sentences in some circumtances of Law violation and joint reponsibilities for the violation. Therefore, GM product owners avoid to make application for approval and non product developer have made application till now. Instead, some Turkish assosiations such as poultry producers assosiations, animal feed assosiations have applied to get approval for import of GM products for their members. Thus, name of product applicants are not product developers for our country.


Turkish Feed Manufacturer's Association
Turkish Poultry Meat Producers and Breeders Association
Turkish Egg Producers Association

Upload:
Date of authorization: 24/12/2011
Scope of authorization: Feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
After the evaluation of reports released by Scientific Risk Assessment Committee and Socio- economic Assessment Committee and also by considering public opinion, Biosafety Board has approved the use of genetically modified maize DAS1507 and products thereof for animal feed.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
DG of Agricultural Research and Policies (TAGEM)
Contact person name:
Ramazan BULBUL
Website:
Physical full address:
Universiteler Mah. Dumlupınar Bulvarı, Eskişehir Yolu 10. Km Çankaya/ANKARA/TURKEY
Phone number:
+90 312 307 60 48
Fax number:
+90 312 307 61 90
Country introduction:

Turkey is party to the Cartagena Protocol on Biosafety (CPB) since Jan 24, 2004. Biosafety applications in Turkey are carried out within the framework of the Biosafety Law (no.5977) which entered into force in 26 September 2010 and its relevant regulations (“The Regulation on Genetically Modified Organisms and Products” and “The Regulation Connected with Working Procedure and Principles of Biosafety Board and Committees”). Biosafety Law and two regulations came into force on 26th September 2010.

 Main objectives of the Biosafety Law are;

  • to prevent risks that may arise from GMO’s and products which are produced by using of modern biotechnology by taking into account scientific and technological developments;
  • to establish and implement biosafety system to ensure protection and sustainability of environment, biological diversity and health of human, animal and plant;
  • to inspect, regulate and monitor the activities in the scope of the law.

 The Law includes specific points regarding research, development, processing, releasing on the market, monitoring, using, import, export, handling, transportation, packaging, labelling, storage and similar operations in relation to GMO and GMOPs.

 Veterinarian medicinal products and medicinal products for human use and also cosmetic products which are permitted or certified by the Ministry of Health are out of this Law’s scope. 

 According to Biosafety Law following actions connected with GMO and GMOPs are prohibited:

  • Releasing  GMO and GMOPs on the market without approval of Ministry of Agriculture and Forestry.
  • Production of genetically modified plants and animals.
  • Using GMO and GMOPs in baby food and baby formulae, follow-on baby food and follow-on formulae, infant and kid’s nutritional supplements

 According to the Biosafety Law, which was enacted in 2010, the Biosafety Board, which was established within the scope of the Law, was responsible for evaluating the applications regarding GMO and its products.

 However, the duties and powers of the Biosafety Board were assigned to the Ministry of Agriculture and Forestry with the Presidential Circular No. 2018/3 published in the Official Gazette on the date of August 2, 2018.

 The task of evaluating the applications related to GMO and its products, performing the secretarial services of the Committees and other duties specified in the Biosafety Law and related regulations has been assigned to General Directorate of Agricultural Research and Policies (TAGEM) under the Ministry of Agriculture and Forestry pursuant to Ministerial Approval dated 05/12/2018.

 Ministry of Agriculture and Forestry makes a “Decision” about applications on GMO and products via taking Scientific Committees’ risk assessment and socio-economic assessment into account.

 For each application the Ministry of Agriculture and Forestry assigns a new committee and each committee makes different assessment for each application. It is important to note that in Turkey food and feed each have a different assessment application.

 Members of scientific committees are selected from the List of Experts.

 11 members are selected for each GMO application.

 List of Experts has been made up by the evaluation of Ministry of Agriculture and Forestry from the applicants who applied via using the Biosafety Clearing-House Mechanism of Turkey. Applicants were faculty members and experts of Universities and TÜBİTAK (The Scientific and Technological Research Council of Turkey).

 To date, 13 types of GM soybean and 23 types of GM maize were approved as feed for import.

Besides, by the use of aspergillus oryzae, developed through modern biotechnological methods, licences for industrial α-amylase, glucoamylase and hemicellulase enzyme production were granted.

 Threshold of labeling of GMO products that are approved by Ministry of Agriculture and Forestry is 0.9%.

There are not any applications for using GMO and products as food.

 After placing GMO and GMOPs on the market; the Ministry controls and inspects whether or not conditions designated by decision are met.

Activities of analysis are performed in laboratories designated by the Ministry.

In the case of any non-compliance detected with relation to the GMO Legislation (such as  a failure to specify the contained GMO on the label, identification of an unapproved gene, etc.) legal action is taken.

Application evaluation process is like below:

  • Evaluation of application by Ministry of Agriculture and Forestry      90 days
  • Feedback to the applicant                                                            15 days
  • Ministry of Agriculture and Forestry’s “Decision”                             270 days

(Starts from feedback to the applicant)

Establishing of Scientific Committees

Report preparation of Committees

Report’s public release

Evaluation of public opinions by Committees

Ministry of Agriculture and Forestry’s final decision after taking reports and public opinions into     

account

  • Publishing the Positive Decision                                                        30 days
  • Reclamation period to Negative Decision                                           60 days
  • Evaluation of reclamation by Ministry of Agriculture and Forestry        60 days
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Ministry of Agriculture and Forestry

General Directorate of Agricultural Research and Policies

Focal Point of the FAO GM Foods Platform

Ramazan BULBUL

Email: [email protected]

United States of America
Name of product applicant: Dow AgroSciences
Summary of application:

Cry1F Maize

Upload:
Date of authorization: 18/05/2001
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): EPA BRAD
FDA Consultation
Summary of the safety assessment (food safety):
Please see EPA BRAD and FDA consultation.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Food and Drug Administration
Contact person name:
Jason Dietz
Website:
Physical full address:
5100 Paint Branch Parkway, College Park MD 20740
Phone number:
240-402-2282
Fax number:
Country introduction:

The United States is currently in the process of populating this database. The Food and Drug Administration regulates food and feed (food for humans and animals) from genetically engineered crops in conjunction with the Environmental Protection Agency (EPA). EPA regulates pesticides, including those that are plant incorporated protectants genetically engineered into food crops, to make sure that pesticide residues are safe for human and animal consumption and do not pose unreasonable risks of harm to human health or the environment. FDA In the Federal Register of May 29, 1992 (57 FR 22984), FDA published its "Statement of Policy: Foods Derived from New Plant Varieties" (the 1992 policy). The 1992 policy clarified the agency's interpretation of the application of the Federal Food, Drug, and Cosmetic Act with respect to human and animal foods derived from new plant varieties and provided guidance to industry on scientific and regulatory issues related to these foods. The 1992 policy applied to all foods derived from all new plant varieties, including varieties that are developed using genetic engineering (also known as recombinant deoxyribonucleic acid (rDNA) technology). In the 1992 policy, FDA recommended that developers consult with FDA about foods from genetically engineered plants under development and developers have routinely done so. In June 1996, FDA provided additional guidance to industry on procedures for these consultations (the consultation procedures). These procedures describe a process in which a developer who intends to commercialize food from a genetically engineered plant meets with the agency to identify and discuss relevant safety, nutritional, or other regulatory issues regarding the genetically engineered food and then submits to FDA a summary of its scientific and regulatory assessment of the food. FDA evaluates the submission and if FDA has questions about the summary provided, it requests clarification from the developer. At the conclusion of the consultation FDA responds to the developer by letter. The approach to the safety assessment of genetically engineered food recommended by FDA during consultations, including data and information evaluated, is consistent with that described in the Codex Alimentarius Guideline for the Conduct of Food Safety Assessment of Foods Derived from Recombinant-DNA Plants. EPA The safe use of pesticidal substances is regulated by EPA. Food from a genetically engineered plant that is the subject of a consultation with FDA may contain an introduced pesticidal substance, also known as a plant-incorporated protectant (PIP), that is subject to food (food for humans and animals) safety and environmental review by EPA. PIPs are pesticidal substances produced by plants and the genetic material necessary for the plant to produce the substance. Both the PIP protein and its genetic material are regulated by EPA. When assessing the potential risks of PIPs, EPA requires studies examining numerous factors, such as risks to human health, non-target organisms and the environment, potential for gene flow, and insect resistance management plans, if needed. In regulating PIPs, decisions are based on scientific standards and input from academia, industry, other Federal agencies, and the public. Before the first PIP product was registered in 1995, EPA required that PIP products be thoroughly tested against human safety standards before they were used on human food and livestock feed crops. EPA scientists assessed a wide variety of potential effects associated with the use of PIPs, including toxicity, and allergenicity. These potential effects were evaluated in light of the public's potential exposures to these pesticides, taking into account all potential combined sources of the exposure (food, drinking water, etc.) to determine the likelihood that a person exposed at these levels would be predisposed to a health risk. Based on its reviews of the scientific studies and often peer reviews by the Federal Insecticide, Fungicide and Rodenticide Scientific Advisory Panel, EPA determined that these genetically engineered PIP products, when used in accordance with approved label directions and use restrictions, would not pose unreasonable risk to human health and the environment during their time-limited registration.

Useful links
Relevant documents
Stacked events:

Stacked events that are each plant incorporated protectants, as defined by the Environmental Protection Agency, must be registered by the Envriornmental Protection Agency before they can be commercialized.  Food/feed safety asssessment of single events are generally sufficient to ensure the safety of food/feed from stacked events.   

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

Food and Drug Administration ([email protected]); Environmental Protection Agency

Uruguay
Name of product applicant: Dow AgroSciences
Summary of application:

Corm modified with the insertion of the Cry1F gene from Bacillus thuringiensis to confer resistance to the European corn borer (Ostrinia nubilalis). A transformation cassette coding for phosphinothricin (PPT) herbicide tolerance, specifically glufosinate ammonium, was also inserted into the organism.

Upload:
Date of authorization: 21/06/2011
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): BCH
Summary of the safety assessment (food safety):
Please refer to uploaded document
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: GNBio
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Ministerio de Ganadería, Agricultura y Pesca
Contact person name:
Alejandra Ferenczi
Website:
Physical full address:
Constituyente 1476, Piso 2, Of. 212B. Montevideo, Uruguay
Phone number:
+598 2 4104155 int 3
Fax number:
Country introduction:

The Uruguayan National Biosafety System (SNB for its acronym in Spanish) includes safety assessments of food end feed, environmental risk assessment, risk management, and risk communication. The National Biosafety Cabinet (GNBio) is the competent authority on biosafety of GMOs. Integrated by: The Minister of Agriculture, MGAP (chair); Minister of Health (MSP); Minister of Economy (MEF); Minister of Environment (MVOTMA); Minister of Foreign Affairs (MRREE); and Minister of Industry (MIEM). This Cabinet is the last responsible to make decisions over a submitted request. It has the authority to define policies to be followed with respect to biosafety in all scopes of GMO application. Other committees of experts and scientists give support to decisions of GNBio through risk analysis of biotechnological products. The Risk Management Commission (CGR) is composed by one delegate of each of the ministries represented within GNBio.  The CGR advises GNBio on GMO biosecurity issues; elaborates reference terms for risk assessments; manages the risk communication participation process; is responsible for follow-up and monitoring of authorized events. The Risk Assessment in Biosecurity (ERB) is composed of experts proposed by the CGR and designated by GNBio among specialists in the different areas of risk assessment. Is responsible for considering, on a case-by-case basis, the potential risks and benefits of each new biotech product; assure case-by-case risk assessment evaluation based on scientific methods; writes an operational plan (pre-report) of risk assessment according to CGR directives; advises CGR based on the results of the analysis of risk assessment, and provides information during the consultation process. The Institutional Articulation Committee (CAI) is a committee of technical experts from nine different national public and research institutions, which analyzes the risk assessment of new events and prepares a technical report. The technical analysis is coordinated by ERB organized in different ad hoc groups of experts. The Ad hoc experts groups are technical-scientific specialists in different areas of knowledge related to the analysis of GMO events like characterization and molecular identification of events, environmental and food safety aspects. 

Useful links
Relevant documents
Stacked events:

GM vegetables from cross-pollinated species, such as corn, with stacked events are not considered as a new product. In the case of GM vegetables from self-pollinated species, such as soybean, are considered as a new product even if all single events stacked have already been approved. However, there is an abbreviated analysis procedure in cases where single events were already analyzed. Stacked events not yet analyzed must have the individual risk assessment report.

Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:

GNBio office. E-mail: [email protected]; Adress: Constituyente 1476, piso 2, oficina 212B, Montevideo 11200, Uruguay.

Vietnam
Name of product applicant: TC 1507
Summary of application:

The 1507 maize expresses the Cry1F and PAT proteins that confer protection against certain lepidopteran pests such as the European corn borer (Ostrinia nubilalis) and Asian corn borer (Ostrinia furnacalis), as well as tolerance to glufosinate-ammonium herbicides, respectively.

Upload:
Date of authorization: 19/01/2016
Scope of authorization: Food and feed
Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.):
Summary of the safety assessment (food safety):
Overall, the analyses conducted on the safety of 1507 maize concludes that 1507 maize does not pose a greater risk than non-GM maize varieties in food and feed. Molecular characterization confirmed that 1507 maize contains a single, intact insertion of the T-DNA from plasmid PHI899A that is stable across multiple generations and segregates according to Mendel’s laws of genetics. The introduced genes in 1507 maize express the Cry1F and PAT proteins. Compositional studies have confirmed that 1507 maize is substantially equivalent to conventional maize. Proximates, amino acid, fatty acid, vitamins and mineral composition of 1507 maize are comparable with its non-transgenic isoline and within the normal range of conventional maize. Therefore, 1507 maize is considered substantially equivalent and as safe as conventional maize. The specificity of the Cry1F protein expressed in 1507 has been well-established and is limited to lepidopteran pest species. The safety of the PAT protein has also been well established. The Cry1F and PAT proteins were found not to be acutely toxic in mice. No significant homology to known nucleic acid sequences that code for a protein toxic to humans or antibiotic resistance have been introduced into 1507 maize. Similarly, no significant homology was demonstrated for the Cry1F and PAT proteins with known allergens, and both proteins have little probability of being allergenic. The Cry1F and Pat proteins are rapidly degraded in digestibility experiments. Also, Cry proteins originating from Bacillus thuringiensis have a long history of safe use as microbial pesticides and there remains no evidence of harmful effects caused by Cry proteins on humans or vertebrate animals. 1507 maize when used as food and feed is not expected to cause adverse effects. There is a long history of safe use surrounding the cultivation of 1507 maize. To date, 1507 maize has been approved for usage for food and/or feed in 18 different countries, granted certificates of environmental safety in 11 countries and cultivated at 9 countries worldwide.
Upload:
Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained:
Relevant links to documents and information prepared by the competent authority responsible for the safety assessment:
Upload:
Authorization expiration date (a blank field means there is no expiration date)
E-mail:
Organization/agency name (Full name):
Ministry of Agriculture and Rural development
Contact person name:
Nguyen Thi Thanh Thuy
Website:
Physical full address:
2, Ngoc Ha, Ba Dinh, Ha Noi, Viet Nam
Phone number:
+84 08044643
Fax number:
+83 4 38433637
Country introduction:

The process for authorizing a GM food, feed is based on the Vietnam regulation on GM food and feed (Circular No. 02/2014/TT-BNNPTNT). An application for authorizing food, feed derived or made from a GM plant must be submitted to national authorities (Ministry of Agriculture and Rural Development-MARD). The national authority proceeds prior review the dossier/application and makes the application summary report available to the public. The authority then sends the application to the Food, Feed Safety Committee (FFSC) members for reviewing and risk assessment. FFSC is inter-ministerial committee established by the Minister of Agriculture and Rural Development in order to consult to MARD’s minister for issuance, revocation the Food, feed safety Certificate. Once FFSC performing the risk assessment (desktop reviewing), the public has 30 days to comment on MARD website for application. Within 180 days of receiving the appropriate application, FFSC complete the assessment and submit the final report to the national authority/MARD under Circular 02/2014/TT-BNNPTNT. Within 30 days receiving FFSC comment and conclusion, the national authority grants or refuses to issuing certificate.

Safety regulations have derived based upon the internationally established scientific guidelines and principles of Codex Alimentarius Commission, FAO, WHO and OECD.

FFSC does not separately assess food, feed from stacked event lines where food, feed from the GM parental events has already been approved separately; Mandate notification of stacked events by developers.

Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant: